NZ619465B2 - Fluorination of aromatic ring systems - Google Patents
Fluorination of aromatic ring systems Download PDFInfo
- Publication number
- NZ619465B2 NZ619465B2 NZ619465A NZ61946512A NZ619465B2 NZ 619465 B2 NZ619465 B2 NZ 619465B2 NZ 619465 A NZ619465 A NZ 619465A NZ 61946512 A NZ61946512 A NZ 61946512A NZ 619465 B2 NZ619465 B2 NZ 619465B2
- Authority
- NZ
- New Zealand
- Prior art keywords
- compound
- formula
- protecting group
- group
- independently
- Prior art date
Links
- 125000003118 aryl group Chemical group 0.000 title claims description 17
- 238000003682 fluorination reaction Methods 0.000 title description 4
- 150000001875 compounds Chemical class 0.000 claims abstract description 143
- WEVYAHXRMPXWCK-UHFFFAOYSA-N acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 71
- 238000010438 heat treatment Methods 0.000 claims description 61
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 55
- -1 phan Chemical compound 0.000 claims description 51
- 239000000203 mixture Substances 0.000 claims description 43
- 125000005418 aryl aryl group Chemical group 0.000 claims description 40
- 239000011780 sodium chloride Substances 0.000 claims description 38
- 150000003839 salts Chemical class 0.000 claims description 37
- 239000002904 solvent Substances 0.000 claims description 34
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 30
- 239000012454 non-polar solvent Substances 0.000 claims description 27
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 26
- YMWUJEATGCHHMB-UHFFFAOYSA-N methylene dichloride Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 24
- 239000002798 polar solvent Substances 0.000 claims description 21
- LJQLCJWAZJINEB-UHFFFAOYSA-N Hexafluorophosphate Chemical compound F[P-](F)(F)(F)(F)F LJQLCJWAZJINEB-UHFFFAOYSA-N 0.000 claims description 20
- YXFVVABEGXRONW-UHFFFAOYSA-N toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 20
- 229910052731 fluorine Inorganic materials 0.000 claims description 19
- 125000006239 protecting group Chemical group 0.000 claims description 19
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 claims description 17
- 239000000356 contaminant Substances 0.000 claims description 17
- 238000004587 chromatography analysis Methods 0.000 claims description 16
- 125000006241 alcohol protecting group Chemical group 0.000 claims description 15
- 125000001072 heteroaryl group Chemical group 0.000 claims description 15
- QVGXLLKOCUKJST-UHFFFAOYSA-N oxygen atom Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 15
- 125000006244 carboxylic acid protecting group Chemical group 0.000 claims description 13
- 239000011737 fluorine Substances 0.000 claims description 13
- YCKRFDGAMUMZLT-UHFFFAOYSA-N fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 claims description 13
- 150000002500 ions Chemical class 0.000 claims description 12
- 230000002285 radioactive Effects 0.000 claims description 12
- 229940035295 Ting Drugs 0.000 claims description 11
- 229910052757 nitrogen Inorganic materials 0.000 claims description 11
- 125000001424 substituent group Chemical group 0.000 claims description 11
- VLKZOEOYAKHREP-UHFFFAOYSA-N hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 10
- WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N acetic acid ethyl ester Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 9
- 239000002253 acid Substances 0.000 claims description 8
- 125000004429 atoms Chemical group 0.000 claims description 8
- 239000008079 hexane Substances 0.000 claims description 7
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 7
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims description 7
- 229910052708 sodium Inorganic materials 0.000 claims description 7
- 239000011734 sodium Substances 0.000 claims description 7
- JOXIMZWYDAKGHI-UHFFFAOYSA-M toluene-4-sulfonate Chemical compound CC1=CC=C(S([O-])(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-M 0.000 claims description 7
- VZGDMQKNWNREIO-UHFFFAOYSA-N Carbon tetrachloride Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 claims description 6
- MVPPADPHJFYWMZ-UHFFFAOYSA-N Chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 claims description 6
- LQNUZADURLCDLV-UHFFFAOYSA-N Nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 claims description 6
- VLTRZXGMWDSKGL-UHFFFAOYSA-M Perchlorate Chemical compound [O-]Cl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-M 0.000 claims description 6
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 claims description 6
- ITMCEJHCFYSIIV-UHFFFAOYSA-N Trifluoromethanesulfonic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 claims description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 6
- 125000000304 alkynyl group Chemical group 0.000 claims description 6
- 125000001188 haloalkyl group Chemical group 0.000 claims description 6
- 239000001301 oxygen Substances 0.000 claims description 6
- 229910052760 oxygen Inorganic materials 0.000 claims description 6
- CPELXLSAUQHCOX-UHFFFAOYSA-M bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 claims description 5
- 239000002739 cryptand Substances 0.000 claims description 5
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 claims description 5
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims description 5
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 5
- 229910052700 potassium Inorganic materials 0.000 claims description 5
- 239000011591 potassium Substances 0.000 claims description 5
- 125000006374 C2-C10 alkenyl group Chemical group 0.000 claims description 4
- TVFDJXOCXUVLDH-UHFFFAOYSA-N Cesium Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 claims description 4
- PYLWMHQQBFSUBP-UHFFFAOYSA-N Fluorobenzene Chemical compound FC1=CC=CC=C1 PYLWMHQQBFSUBP-UHFFFAOYSA-N 0.000 claims description 4
- 229910052792 caesium Inorganic materials 0.000 claims description 4
- 150000003983 crown ethers Chemical class 0.000 claims description 4
- SPXOTSHWBDUUMT-UHFFFAOYSA-M 4-nitrobenzenesulfonate Chemical compound [O-][N+](=O)C1=CC=C(S([O-])(=O)=O)C=C1 SPXOTSHWBDUUMT-UHFFFAOYSA-M 0.000 claims description 3
- IVSZLXZYQVIEFR-UHFFFAOYSA-N M-Xylene Chemical group CC1=CC=CC(C)=C1 IVSZLXZYQVIEFR-UHFFFAOYSA-N 0.000 claims description 3
- JGTNAGYHADQMCM-UHFFFAOYSA-N Perfluorobutanesulfonic acid Chemical compound OS(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F JGTNAGYHADQMCM-UHFFFAOYSA-N 0.000 claims description 3
- GETTZEONDQJALK-UHFFFAOYSA-N Trifluorotoluene Chemical compound FC(F)(F)C1=CC=CC=C1 GETTZEONDQJALK-UHFFFAOYSA-N 0.000 claims description 3
- XDTMQSROBMDMFD-UHFFFAOYSA-N cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N ethylbenzene Chemical compound CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 claims description 3
- 229940058172 ethylbenzene Drugs 0.000 claims description 3
- WHXSMMKQMYFTQS-UHFFFAOYSA-N lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 3
- 229910052744 lithium Inorganic materials 0.000 claims description 3
- AFVFQIVMOAPDHO-UHFFFAOYSA-N methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims description 3
- URLKBWYHVLBVBO-UHFFFAOYSA-N p-xylene Chemical group CC1=CC=C(C)C=C1 URLKBWYHVLBVBO-UHFFFAOYSA-N 0.000 claims description 3
- ODGCEQLVLXJUCC-UHFFFAOYSA-N tetrafluoroborate Chemical compound F[B-](F)(F)F ODGCEQLVLXJUCC-UHFFFAOYSA-N 0.000 claims description 3
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 2
- 229960005190 Phenylalanine Drugs 0.000 claims description 2
- SVHQOIWIRUVWII-UHFFFAOYSA-N Tetraphenylborate Chemical compound C1=CC=CC=C1[B-](C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 SVHQOIWIRUVWII-UHFFFAOYSA-N 0.000 claims description 2
- 125000003342 alkenyl group Chemical group 0.000 claims description 2
- 125000004432 carbon atoms Chemical group C* 0.000 claims description 2
- 238000001722 flash pyrolysis Methods 0.000 claims description 2
- 125000004433 nitrogen atoms Chemical group N* 0.000 claims 5
- 239000007795 chemical reaction product Substances 0.000 claims 4
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 claims 1
- 229960005309 Estradiol Drugs 0.000 claims 1
- 238000004255 ion exchange chromatography Methods 0.000 claims 1
- 229910052698 phosphorus Inorganic materials 0.000 claims 1
- 238000002360 preparation method Methods 0.000 abstract description 34
- 230000015572 biosynthetic process Effects 0.000 abstract description 17
- 238000003786 synthesis reaction Methods 0.000 abstract description 16
- 230000002194 synthesizing Effects 0.000 abstract description 16
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 10
- 150000001501 aryl fluorides Chemical class 0.000 abstract description 7
- 150000001413 amino acids Chemical class 0.000 abstract description 3
- 239000002773 nucleotide Substances 0.000 abstract description 3
- 125000003729 nucleotide group Chemical group 0.000 abstract description 3
- 150000001491 aromatic compounds Chemical class 0.000 abstract description 2
- 150000002390 heteroarenes Chemical class 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 56
- 239000011541 reaction mixture Substances 0.000 description 40
- KRHYYFGTRYWZRS-UHFFFAOYSA-M fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 31
- 238000006243 chemical reaction Methods 0.000 description 25
- 238000000034 method Methods 0.000 description 19
- 230000000875 corresponding Effects 0.000 description 17
- FPGGTKZVZWFYPV-UHFFFAOYSA-M Tetra-n-butylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 16
- OZAIFHULBGXAKX-UHFFFAOYSA-N precursor Substances N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 16
- 125000005520 diaryliodonium group Chemical group 0.000 description 14
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 14
- 238000001914 filtration Methods 0.000 description 13
- GTDKXDWWMOMSFL-UHFFFAOYSA-M tetramethylazanium;fluoride Chemical compound [F-].C[N+](C)(C)C GTDKXDWWMOMSFL-UHFFFAOYSA-M 0.000 description 13
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
- 239000007787 solid Substances 0.000 description 11
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 10
- 239000002198 insoluble material Substances 0.000 description 10
- 239000003921 oil Substances 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- MGFYSGNNHQQTJW-UHFFFAOYSA-N iodonium Chemical class [IH2+] MGFYSGNNHQQTJW-UHFFFAOYSA-N 0.000 description 8
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 8
- 238000007792 addition Methods 0.000 description 7
- 238000000354 decomposition reaction Methods 0.000 description 7
- 239000011550 stock solution Substances 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 238000001704 evaporation Methods 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- 125000000524 functional group Chemical group 0.000 description 6
- 239000012299 nitrogen atmosphere Substances 0.000 description 6
- 239000012071 phase Substances 0.000 description 6
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 6
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 6
- 229910052710 silicon Inorganic materials 0.000 description 6
- 239000010703 silicon Substances 0.000 description 6
- ZSLANEPPMBPVCI-UHFFFAOYSA-L (4-methoxyphenyl)iodanium;diacetate Chemical compound CC([O-])=O.CC([O-])=O.COC1=CC=C([IH+])C=C1.COC1=CC=C([IH+])C=C1 ZSLANEPPMBPVCI-UHFFFAOYSA-L 0.000 description 5
- GRUPMMBRLDBTDD-UHFFFAOYSA-N 3-[2-(2-methyl-1,3-thiazol-4-yl)ethynyl]benzonitrile Chemical compound S1C(C)=NC(C#CC=2C=C(C=CC=2)C#N)=C1 GRUPMMBRLDBTDD-UHFFFAOYSA-N 0.000 description 5
- RDOXTESZEPMUJZ-UHFFFAOYSA-N Anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 5
- PAXWQORCRCBOCU-LURJTMIESA-N Fluorodopa Chemical compound OC(=O)[C@@H](N)CC1=CC(O)=C(O)C=C1F PAXWQORCRCBOCU-LURJTMIESA-N 0.000 description 5
- CFVOYVCHUHLMBP-UHFFFAOYSA-N bis(4-methoxyphenyl)iodanium;hexafluorophosphate Chemical compound F[P-](F)(F)(F)(F)F.C1=CC(OC)=CC=C1[I+]C1=CC=C(OC)C=C1 CFVOYVCHUHLMBP-UHFFFAOYSA-N 0.000 description 5
- 238000002523 gelfiltration Methods 0.000 description 5
- JXFFLAUBZOJVRY-UHFFFAOYSA-M iodanium;trifluoromethanesulfonate Chemical compound [IH2+].[O-]S(=O)(=O)C(F)(F)F JXFFLAUBZOJVRY-UHFFFAOYSA-M 0.000 description 5
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 5
- 239000004810 polytetrafluoroethylene Substances 0.000 description 5
- 238000006467 substitution reaction Methods 0.000 description 5
- CCSCCVLBMDKDBP-UHFFFAOYSA-N tributyl-(3,4-dimethoxyphenyl)stannane Chemical compound CCCC[Sn](CCCC)(CCCC)C1=CC=C(OC)C(OC)=C1 CCSCCVLBMDKDBP-UHFFFAOYSA-N 0.000 description 5
- 229960000583 Acetic Acid Drugs 0.000 description 4
- 150000001450 anions Chemical class 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 4
- 229960004132 diethyl ether Drugs 0.000 description 4
- 238000005342 ion exchange Methods 0.000 description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 description 4
- 235000015320 potassium carbonate Nutrition 0.000 description 4
- 230000002633 protecting Effects 0.000 description 4
- 238000001542 size-exclusion chromatography Methods 0.000 description 4
- 125000003107 substituted aryl group Chemical group 0.000 description 4
- SYSZENVIJHPFNL-UHFFFAOYSA-N 1-iodo-4-methoxybenzene Chemical compound COC1=CC=C(I)C=C1 SYSZENVIJHPFNL-UHFFFAOYSA-N 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- IVRMZWNICZWHMI-UHFFFAOYSA-N azide Chemical compound [N-]=[N+]=[N-] IVRMZWNICZWHMI-UHFFFAOYSA-N 0.000 description 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-M benzoate Chemical compound [O-]C(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-M 0.000 description 3
- 239000012043 crude product Substances 0.000 description 3
- XLJMAIOERFSOGZ-UHFFFAOYSA-M cyanate Chemical compound [O-]C#N XLJMAIOERFSOGZ-UHFFFAOYSA-M 0.000 description 3
- 230000001809 detectable Effects 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 150000002222 fluorine compounds Chemical group 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 3
- 239000011261 inert gas Substances 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-M phenolate Chemical compound [O-]C1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-M 0.000 description 3
- 235000021317 phosphate Nutrition 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 150000007944 thiolates Chemical class 0.000 description 3
- 229910052718 tin Inorganic materials 0.000 description 3
- GOYDNIKZWGIXJT-UHFFFAOYSA-N 1,2-Difluorobenzene Chemical compound FC1=CC=CC=C1F GOYDNIKZWGIXJT-UHFFFAOYSA-N 0.000 description 2
- WEVYAHXRMPXWCK-FIBGUPNXSA-N 2,2,2-trideuterioacetonitrile Chemical compound [2H]C([2H])([2H])C#N WEVYAHXRMPXWCK-FIBGUPNXSA-N 0.000 description 2
- LEZZSPMYYQOQRD-UHFFFAOYSA-N 2,2,2-trifluoroethanolate Chemical compound [O-]CC(F)(F)F LEZZSPMYYQOQRD-UHFFFAOYSA-N 0.000 description 2
- WGAFQMMKTNUYDH-UHFFFAOYSA-N 2-(2-bromo-4,5-dimethoxyphenyl)ethanamine Chemical compound COC1=CC(Br)=C(CCN)C=C1OC WGAFQMMKTNUYDH-UHFFFAOYSA-N 0.000 description 2
- AFABGHUZZDYHJO-UHFFFAOYSA-N 2-Methylpentane Chemical class CCCC(C)C AFABGHUZZDYHJO-UHFFFAOYSA-N 0.000 description 2
- RAXXELZNTBOGNW-UHFFFAOYSA-N Imidazole Chemical compound C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 2
- 229910019398 NaPF6 Inorganic materials 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- KMADQUOCJBLXRP-UHFFFAOYSA-N Sodium hexafluorophosphate Chemical compound [Na+].F[P-](F)(F)(F)(F)F KMADQUOCJBLXRP-UHFFFAOYSA-N 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N Triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K [O-]P([O-])([O-])=O Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 125000001769 aryl amino group Chemical group 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- DSALILVWXNPMMK-UHFFFAOYSA-M bis(4-methoxyphenyl)iodanium;4-methylbenzenesulfonate Chemical compound CC1=CC=C(S([O-])(=O)=O)C=C1.C1=CC(OC)=CC=C1[I+]C1=CC=C(OC)C=C1 DSALILVWXNPMMK-UHFFFAOYSA-M 0.000 description 2
- KVGPQVFGSFMCTA-UHFFFAOYSA-M bis(4-methoxyphenyl)iodanium;fluoride Chemical compound [F-].C1=CC(OC)=CC=C1[I+]C1=CC=C(OC)C=C1 KVGPQVFGSFMCTA-UHFFFAOYSA-M 0.000 description 2
- 125000001246 bromo group Chemical group Br* 0.000 description 2
- XJHCXCQVJFPJIK-UHFFFAOYSA-M caesium fluoride Inorganic materials [F-].[Cs+] XJHCXCQVJFPJIK-UHFFFAOYSA-M 0.000 description 2
- 150000004657 carbamic acid derivatives Chemical class 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 238000011033 desalting Methods 0.000 description 2
- LROMFDHROPKFSO-UHFFFAOYSA-N dioxidophosphane Chemical compound [O-]P[O-] LROMFDHROPKFSO-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 150000002159 estradiols Chemical class 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000806 fluorine-19 nuclear magnetic resonance spectrum Methods 0.000 description 2
- 238000005755 formation reaction Methods 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M isothiocyanate Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 150000004682 monohydrates Chemical class 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L na2so4 Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 125000002524 organometallic group Chemical group 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- NJRWNWYFPOFDFN-UHFFFAOYSA-L phosphonate(2-) Chemical compound [O-][P]([O-])=O NJRWNWYFPOFDFN-UHFFFAOYSA-L 0.000 description 2
- 125000003367 polycyclic group Chemical group 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- KWYUFKZDYYNOTN-UHFFFAOYSA-M potassium hydroxide Inorganic materials [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Inorganic materials [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 235000013024 sodium fluoride Nutrition 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 125000005207 tetraalkylammonium group Chemical class 0.000 description 2
- MANNXDXMUHZSRP-UHFFFAOYSA-M tetramethylazanium;trifluoromethanesulfonate Chemical compound C[N+](C)(C)C.[O-]S(=O)(=O)C(F)(F)F MANNXDXMUHZSRP-UHFFFAOYSA-M 0.000 description 2
- 230000001131 transforming Effects 0.000 description 2
- REDSKZBUUUQMSK-UHFFFAOYSA-N tributyltin Chemical compound CCCC[Sn](CCCC)CCCC.CCCC[Sn](CCCC)CCCC REDSKZBUUUQMSK-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- QOWBXWFYRXSBAS-UHFFFAOYSA-N (2,4-dimethoxyphenyl)methanamine Chemical compound COC1=CC=C(CN)C(OC)=C1 QOWBXWFYRXSBAS-UHFFFAOYSA-N 0.000 description 1
- DLNKLXBLKHWUHV-UHFFFAOYSA-N (4-methoxyphenyl)iodanium Chemical compound COC1=CC=C([IH+])C=C1 DLNKLXBLKHWUHV-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N 1,2-ethanediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- IDPURXSQCKYKIJ-UHFFFAOYSA-N 1-(4-methoxyphenyl)methanamine Chemical compound COC1=CC=C(CN)C=C1 IDPURXSQCKYKIJ-UHFFFAOYSA-N 0.000 description 1
- JIXDOBAQOWOUPA-UHFFFAOYSA-N 1-fluoro-2-methoxybenzene Chemical compound COC1=CC=CC=C1F JIXDOBAQOWOUPA-UHFFFAOYSA-N 0.000 description 1
- MFJNOXOAIFNSBX-UHFFFAOYSA-N 1-fluoro-3-methoxybenzene Chemical compound COC1=CC=CC(F)=C1 MFJNOXOAIFNSBX-UHFFFAOYSA-N 0.000 description 1
- VIPWUFMFHBIKQI-UHFFFAOYSA-N 1-fluoro-4-methoxybenzene Chemical compound COC1=CC=C(F)C=C1 VIPWUFMFHBIKQI-UHFFFAOYSA-N 0.000 description 1
- LCFVNOPFCICOIS-UHFFFAOYSA-N 1-methyl-2-(3-phenylprop-1-ynyl)benzene Chemical compound CC1=CC=CC=C1C#CCC1=CC=CC=C1 LCFVNOPFCICOIS-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
- BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical compound C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 description 1
- QPLJYAKLSCXZSF-UHFFFAOYSA-N 2,2,2-trichloroethyl carbamate Chemical compound NC(=O)OCC(Cl)(Cl)Cl QPLJYAKLSCXZSF-UHFFFAOYSA-N 0.000 description 1
- CRAJLXHBNCCDPK-UHFFFAOYSA-M 2,2,2-trichloroethyl carbonate Chemical compound [O-]C(=O)OCC(Cl)(Cl)Cl CRAJLXHBNCCDPK-UHFFFAOYSA-M 0.000 description 1
- NRKYWOKHZRQRJR-UHFFFAOYSA-N 2,2,2-trifluoroacetamide Chemical compound NC(=O)C(F)(F)F NRKYWOKHZRQRJR-UHFFFAOYSA-N 0.000 description 1
- NFEDVUHQPSUGNI-UHFFFAOYSA-N 2-(2,3-dimethoxy-6-tributylstannylphenyl)isoindole-1,3-dione Chemical compound CCCC[Sn](CCCC)(CCCC)C1=CC=C(OC)C(OC)=C1N1C(=O)C2=CC=CC=C2C1=O NFEDVUHQPSUGNI-UHFFFAOYSA-N 0.000 description 1
- XKBUFTXNLBWTFP-UHFFFAOYSA-N 2-(2,3-dimethoxyphenyl)ethanamine Chemical compound COC1=CC=CC(CCN)=C1OC XKBUFTXNLBWTFP-UHFFFAOYSA-N 0.000 description 1
- JUSXLWAFYVKNLT-UHFFFAOYSA-M 2-bromobenzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1Br JUSXLWAFYVKNLT-UHFFFAOYSA-M 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-M 2-methylbenzenesulfonate Chemical compound CC1=CC=CC=C1S([O-])(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-M 0.000 description 1
- HWTDMFJYBAURQR-UHFFFAOYSA-M 2-nitrobenzenesulfonate Chemical compound [O-][N+](=O)C1=CC=CC=C1S([O-])(=O)=O HWTDMFJYBAURQR-UHFFFAOYSA-M 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- AUFVJZSDSXXFOI-UHFFFAOYSA-N 2.2.2-Cryptand Chemical compound C1COCCOCCN2CCOCCOCCN1CCOCCOCC2 AUFVJZSDSXXFOI-UHFFFAOYSA-N 0.000 description 1
- ANOUKFYBOAKOIR-UHFFFAOYSA-N 3,4-Dimethoxyphenethylamine Chemical compound COC1=CC=C(CCN)C=C1OC ANOUKFYBOAKOIR-UHFFFAOYSA-N 0.000 description 1
- CPBZARXQRZTYGI-UHFFFAOYSA-N 3-cyclopentylpropylcyclohexane Chemical compound C1CCCCC1CCCC1CCCC1 CPBZARXQRZTYGI-UHFFFAOYSA-N 0.000 description 1
- PEPBFCOIJRULGJ-UHFFFAOYSA-N 3H-1,2,3-benzodioxazole Chemical compound C1=CC=C2NOOC2=C1 PEPBFCOIJRULGJ-UHFFFAOYSA-N 0.000 description 1
- QWKKYJLAUWFPDB-UHFFFAOYSA-N 4-nitrobenzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=C([N+]([O-])=O)C=C1 QWKKYJLAUWFPDB-UHFFFAOYSA-N 0.000 description 1
- VVJKKWFAADXIJK-UHFFFAOYSA-N Allylamine Chemical compound NCC=C VVJKKWFAADXIJK-UHFFFAOYSA-N 0.000 description 1
- MWPLVEDNUUSJAV-UHFFFAOYSA-N Anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 1
- JUHORIMYRDESRB-UHFFFAOYSA-N Benzathine Chemical compound C=1C=CC=CC=1CNCCNCC1=CC=CC=C1 JUHORIMYRDESRB-UHFFFAOYSA-N 0.000 description 1
- IANQTJSKSUMEQM-UHFFFAOYSA-N Benzofuran Chemical compound C1=CC=C2OC=CC2=C1 IANQTJSKSUMEQM-UHFFFAOYSA-N 0.000 description 1
- JFDZBHWFFUWGJE-UHFFFAOYSA-N Benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 1
- IOJUPLGTWVMSFF-UHFFFAOYSA-N Benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 1
- FCEHBMOGCRZNNI-UHFFFAOYSA-N Benzothiophene Chemical compound C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 description 1
- BCMCBBGGLRIHSE-UHFFFAOYSA-N Benzoxazole Chemical compound C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- MPBYXMJLDGTYPN-UHFFFAOYSA-L CC([O-])=O.CC([O-])=O.COC1=CC=CC=C1[IH+].COC1=CC=CC=C1[IH+] Chemical compound CC([O-])=O.CC([O-])=O.COC1=CC=CC=C1[IH+].COC1=CC=CC=C1[IH+] MPBYXMJLDGTYPN-UHFFFAOYSA-L 0.000 description 1
- VDANGULDQQJODZ-UHFFFAOYSA-N Chloroprocaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1Cl VDANGULDQQJODZ-UHFFFAOYSA-N 0.000 description 1
- 229960002023 Chloroprocaine Drugs 0.000 description 1
- 229960001231 Choline Drugs 0.000 description 1
- UHOVQNZJYSORNB-MZWXYZOWSA-N Deuterated benzene Chemical compound [2H]C1=C([2H])C([2H])=C([2H])C([2H])=C1[2H] UHOVQNZJYSORNB-MZWXYZOWSA-N 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N Diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 229940052303 Ethers for general anesthesia Drugs 0.000 description 1
- HEZNVIYQEUHLNI-UHFFFAOYSA-N Ethiofencarb Chemical compound CCSCC1=CC=CC=C1OC(=O)NC HEZNVIYQEUHLNI-UHFFFAOYSA-N 0.000 description 1
- 229940012017 Ethylenediamine Drugs 0.000 description 1
- AZELNWDEHSPSQF-UHFFFAOYSA-N F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F Chemical compound F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F AZELNWDEHSPSQF-UHFFFAOYSA-N 0.000 description 1
- 230000036499 Half live Effects 0.000 description 1
- HOBCFUWDNJPFHB-UHFFFAOYSA-N Indolizine Chemical compound C1=CC=CN2C=CC=C21 HOBCFUWDNJPFHB-UHFFFAOYSA-N 0.000 description 1
- 241000895880 Ioa Species 0.000 description 1
- AWJUIBRHMBBTKR-UHFFFAOYSA-N Isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 1
- CTAPFRYPJLPFDF-UHFFFAOYSA-N Isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 description 1
- MBBZMMPHUWSWHV-BDVNFPICSA-N Meglumine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 1
- 229960003194 Meglumine Drugs 0.000 description 1
- GHFGJTVYMNRGBY-UHFFFAOYSA-N Meta-Tyramine Chemical compound NCCC1=CC=CC(O)=C1 GHFGJTVYMNRGBY-UHFFFAOYSA-N 0.000 description 1
- XBXCNNQPRYLIDE-UHFFFAOYSA-M N-tert-butylcarbamate Chemical compound CC(C)(C)NC([O-])=O XBXCNNQPRYLIDE-UHFFFAOYSA-M 0.000 description 1
- 101710027499 Os03g0268000 Proteins 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N Procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 102000014961 Protein Precursors Human genes 0.000 description 1
- 108010078762 Protein Precursors Proteins 0.000 description 1
- KDCGOANMDULRCW-UHFFFAOYSA-N Purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 1
- PBMFSQRYOILNGV-UHFFFAOYSA-N Pyridazine Chemical compound C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- VDZOOKBUILJEDG-UHFFFAOYSA-M Tetrabutylammonium hydroxide Chemical compound [OH-].CCCC[N+](CCCC)(CCCC)CCCC VDZOOKBUILJEDG-UHFFFAOYSA-M 0.000 description 1
- GCTFWCDSFPMHHS-UHFFFAOYSA-M Tributyltin chloride Chemical compound CCCC[Sn](Cl)(CCCC)CCCC GCTFWCDSFPMHHS-UHFFFAOYSA-M 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- DXPOSRCHIDYWHW-UHFFFAOYSA-N Xamoterol Chemical compound C=1C=C(O)C=CC=1OCC(O)CNCCNC(=O)N1CCOCC1 DXPOSRCHIDYWHW-UHFFFAOYSA-N 0.000 description 1
- PEYBGOKQQPAGSD-UHFFFAOYSA-M [3-cyano-5-[2-(2-methyl-1,3-thiazol-4-yl)ethynyl]phenyl]-(4-methoxyphenyl)iodanium;trifluoromethanesulfonate Chemical group [O-]S(=O)(=O)C(F)(F)F.C1=CC(OC)=CC=C1[I+]C1=CC(C#N)=CC(C#CC=2N=C(C)SC=2)=C1 PEYBGOKQQPAGSD-UHFFFAOYSA-M 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000005599 alkyl carboxylate group Chemical group 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminum Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium Chemical class [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000010936 aqueous wash Methods 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- FYXKZNLBZKRYSS-UHFFFAOYSA-N benzene-1,2-dicarbonyl chloride Chemical compound ClC(=O)C1=CC=CC=C1C(Cl)=O FYXKZNLBZKRYSS-UHFFFAOYSA-N 0.000 description 1
- YIYZHARUXWKUEN-UHFFFAOYSA-N benzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC=C1.NS(=O)(=O)C1=CC=CC=C1 YIYZHARUXWKUEN-UHFFFAOYSA-N 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- PUJDIJCNWFYVJX-UHFFFAOYSA-N benzyl carbamate Chemical compound NC(=O)OCC1=CC=CC=C1 PUJDIJCNWFYVJX-UHFFFAOYSA-N 0.000 description 1
- NJAPCAIWQRPQPY-UHFFFAOYSA-M benzyl carbonate Chemical compound [O-]C(=O)OCC1=CC=CC=C1 NJAPCAIWQRPQPY-UHFFFAOYSA-M 0.000 description 1
- 150000003939 benzylamines Chemical class 0.000 description 1
- 125000002619 bicyclic group Chemical group 0.000 description 1
- DWBJZABVMXQFPV-UHFFFAOYSA-N bis(4-methoxyphenyl)iodanium Chemical compound C1=CC(OC)=CC=C1[I+]C1=CC=C(OC)C=C1 DWBJZABVMXQFPV-UHFFFAOYSA-N 0.000 description 1
- STWXDDJLAMTLIB-UHFFFAOYSA-M bis(4-methoxyphenyl)iodanium;2,2,2-trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F.C1=CC(OC)=CC=C1[I+]C1=CC=C(OC)C=C1 STWXDDJLAMTLIB-UHFFFAOYSA-M 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 101700060525 cahz Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
- 230000003197 catalytic Effects 0.000 description 1
- 239000007805 chemical reaction reactant Substances 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- CRBHXDCYXIISFC-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CC[O-] CRBHXDCYXIISFC-UHFFFAOYSA-N 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- KLYCPFXDDDMZNQ-UHFFFAOYSA-N dehydrobenzene Chemical compound C1=CC#CC=C1 KLYCPFXDDDMZNQ-UHFFFAOYSA-N 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229940043237 diethanolamine Drugs 0.000 description 1
- CQZCVYWWRJDZBO-UHFFFAOYSA-N diphenyliodanium;nitrate Chemical compound [O-][N+]([O-])=O.C=1C=CC=CC=1[I+]C1=CC=CC=C1 CQZCVYWWRJDZBO-UHFFFAOYSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000007345 electrophilic aromatic substitution reaction Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000002708 enhancing Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- DLFVBJFMPXGRIB-UHFFFAOYSA-M ethanimidate Chemical compound CC([O-])=N DLFVBJFMPXGRIB-UHFFFAOYSA-M 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N furane Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 125000005842 heteroatoms Chemical group 0.000 description 1
- 150000002410 histidine derivatives Chemical class 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxyl anion Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 150000002466 imines Chemical class 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- LMQGHUNIJMLWGA-UHFFFAOYSA-M iodanium;fluoride Chemical class [F-].[IH2+] LMQGHUNIJMLWGA-UHFFFAOYSA-M 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 230000000155 isotopic Effects 0.000 description 1
- 230000004301 light adaptation Effects 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- CXHHBNMLPJOKQD-UHFFFAOYSA-M methyl carbonate Chemical compound COC([O-])=O CXHHBNMLPJOKQD-UHFFFAOYSA-M 0.000 description 1
- BAVYZALUXZFZLV-UHFFFAOYSA-O methylammonium Chemical compound [NH3+]C BAVYZALUXZFZLV-UHFFFAOYSA-O 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000006011 modification reaction Methods 0.000 description 1
- 239000005445 natural product Substances 0.000 description 1
- 229930014626 natural products Natural products 0.000 description 1
- 238000010534 nucleophilic substitution reaction Methods 0.000 description 1
- 230000003287 optical Effects 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- 125000001979 organolithium group Chemical group 0.000 description 1
- 150000002902 organometallic compounds Chemical class 0.000 description 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- MZDYAVCNKNXCIS-UHFFFAOYSA-N pent-2-enamide Chemical compound CCC=CC(N)=O MZDYAVCNKNXCIS-UHFFFAOYSA-N 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 150000002993 phenylalanine derivatives Chemical class 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 125000005543 phthalimide group Chemical class 0.000 description 1
- 239000003880 polar aprotic solvent Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000001184 potassium carbonate Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 229960004919 procaine Drugs 0.000 description 1
- BFASWJXWTSCDRR-UHFFFAOYSA-M prop-2-enyl carbonate Chemical compound [O-]C(=O)OC[C]=C BFASWJXWTSCDRR-UHFFFAOYSA-M 0.000 description 1
- 230000001681 protective Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- KYQCOXFCLRTKLS-UHFFFAOYSA-N pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 1
- WTKZEGDFNFYCGP-UHFFFAOYSA-N pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 1
- KAESVJOAVNADME-UHFFFAOYSA-N pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 1
- 230000005258 radioactive decay Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000001187 sodium carbonate Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000012418 sodium perborate tetrahydrate Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 229960001663 sulfanilamide Drugs 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 125000006253 t-butylcarbonyl group Chemical group [H]C([H])([H])C(C(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- DZLFLBLQUQXARW-UHFFFAOYSA-N tetrabutylammonium Chemical compound CCCC[N+](CCCC)(CCCC)CCCC DZLFLBLQUQXARW-UHFFFAOYSA-N 0.000 description 1
- 150000003536 tetrazoles Chemical class 0.000 description 1
- 238000005979 thermal decomposition reaction Methods 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- YTPLMLYBLZKORZ-UHFFFAOYSA-N thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N tin hydride Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- LMYRWZFENFIFIT-UHFFFAOYSA-N toluene-4-sulfonamide Chemical compound CC1=CC=C(S(N)(=O)=O)C=C1 LMYRWZFENFIFIT-UHFFFAOYSA-N 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 150000003852 triazoles Chemical class 0.000 description 1
- PIILXFBHQILWPS-UHFFFAOYSA-N tributyltin Chemical group CCCC[Sn](CCCC)CCCC PIILXFBHQILWPS-UHFFFAOYSA-N 0.000 description 1
- BZVJOYBTLHNRDW-UHFFFAOYSA-N triphenylmethanamine Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(N)C1=CC=CC=C1 BZVJOYBTLHNRDW-UHFFFAOYSA-N 0.000 description 1
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 150000003667 tyrosine derivatives Chemical class 0.000 description 1
- JFALSRSLKYAFGM-UHFFFAOYSA-N uranium(0) Chemical compound [U] JFALSRSLKYAFGM-UHFFFAOYSA-N 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/16—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions not involving the amino or carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C229/36—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C253/00—Preparation of carboxylic acid nitriles
- C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/50—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C269/06—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/62—Compounds containing any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylcarbamates
- C07C271/66—Y being a hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
- C07C41/01—Preparation of ethers
- C07C41/18—Preparation of ethers by reactions not forming ether-oxygen bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/225—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/06—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Abstract
This disclosure relates to reagents and methods useful in the synthesis of aryl fluorides, for example, in the preparation of 18F labelled radiotracers. The reagents and methods provided herein may be used to access a broad range of compounds, including aromatic compounds, heteroaromatic compounds, amino acids, nucleotides, and synthetic compounds. amino acids, nucleotides, and synthetic compounds.
Description
.
Fluorination of Aromatic Ring Systems
FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
The US. ment has certain rights in this invention pursuant to Grant
No. CHE—0717562 awarded by the National e Foundation.
CROSS-REFERENCE TO RELATED APPLICATIONS
This ation claims priority to US. Application Serial No. 13/172,953,
filed on June 30, 2011, entitled FLUORINATION OF IC RING SYSTEMS,
the disclosure of which is incorporated herein by nce.
TECHNICAL FIELD
This disclosure s to reagents and methods useful in the synthesis of aryl
fluorides, for example, in the preparation of 18F labeled radiotracers. The reagents and
s provided herein may be used to access a broad range of compounds,
including aromatic compounds, heteroaromatic compounds, amino acids, nucleotides,
and synthetic compounds.
BACKGROUND
Aryl fluorides are structural moieties in natural products as well as a number
of therapeutically important compounds, including positron emission aphy
(PET) tracers and pharmaceuticals. Therefore s and reagents for producing
such aryl fluorides, for example efficient methods for producing aryl fluorides, are
desirable.
SUMMARY
Provided herein are methods of preparing substituted aryl and heteroaryl ring
systems using diaryliodonium compounds and intermediates. For example,
iodonium salts and diaryliodonium fluorides, as provided herein, can undergo
decomposition to prepare aryl fluorides.
2012/044954
24742004333705.
For example, provided herein is a method for making a compound of Formula (1):
Arz—X
n Ar2 is an aryl or heteroaryl ring system; and X is a moiety wherein the pKa of
the acid H-X is less than 12. In one embodiment, the method includes ng in a
polar solvent a compound MX, wherein M is a counter ion and X is as defined in
Formula (1), and a compound of Formula (2):
Ar‘——I/
wherein Ar1 is an electron rich aryl or heteroaryl ring system; Y is a leaving group;
Ar2 and X are as defined above.
ing reaction, the polar solvent can be removed from the reaction
mixture and the remaining mixture can be combined with a nonpolar solvent and
heated. In some embodiments, the contaminant salts in the solution of the reaction
mixture ofMX and a compound of Formula (2) in the polar solvent can be removed
by chromatography prior to g. For example, the contaminant salts can be
removed by size exclusion, gel filtration, reverse phase, or other tographic
method prior to heating.
In another embodiment, a solution comprising a nonpolar solvent, a compound
MX, and a compound of Formula (2) can be heated to provide a compound of
a (1).
In some embodiments, the nonpolar solution of the reaction e ofMX
and a compound of Formula (2) can be d prior to heating. The filtration step
can remove any insoluble material (e.g., ble salts) that remain in the reaction
mixture. In some embodiments, the solvent can be removed from the filtrate prior to
heating (i.e., the residue can be heated neat).
In further embodiments, the nonpolar solution of the reaction mixture of MX
and a compound of Formula (2) can be filtered prior to heating, the nonpolar solvent
can be removed (e. g., by evaporation), and the heating of the sample can be
performed in a ent solvent.
In some embodiments, the contaminant salts in the solution of the reaction
mixture ofMX and a compound of Formula (2) in the nonpolar solvent can be
04333785.
removed by chromatography prior to heating. For example, the contaminant salts can
be removed by size exclusion, gel ion, reverse phase, or other chromatographic
method prior to heating.
In some embodiments, X can be chosen from halide, aryl carboxylate, alkyl
ylate, phosphate, phosphonate, phosphonite, azide, thiocyanate, cyanate,
phenoxide, trifiate, trifiuoroethoxide, thiolates, and stabilized enolates. For example,
X can be chosen from fluoride, chloride, bromide, iodide, trifiate, roacetate,
benzoate, acetate, phenoxide, trifluoroethoxide, cyanate, azide, thiocyanate, thiolates,
phosphates, and ized enolates. In some embodiments, X is fluoride. In some
1O embodiments, X is a radioactive isotope, for example, X can be a radioactive isotope
of fluoride (e. g., 18F).
The s described herein can be used to prepare fiuorinated aryl or
heteroaryl ring systems (e. g., a radiolabeled fluorinated aryl or heteroaryl ring
system). For example, provided herein is a method of preparing a nd of
Formula (3):
Ar2—F
wherein Ar2 is an aryl or heteroaryl ring system. In one ment, the method
includes reacting in a polar solvent a compound MF, wherein M is a counter ion, and
a nd of a (2), as bed above. Following reaction, the polar solvent
can be removed from the reaction mixture and the remaining mixture can be
combined with a ar solvent and heated. In another embodiment, a solution
comprising a nonpolar solvent, a compound MF, and a compound of Formula (2) can
be heated to e a compound of Formula (3).
In some embodiments, the nonpolar solution of the reaction mixture of MF
and a compound of Formula (2) can be filtered prior to heating. The filtration step
can remove any insoluble material (e.g., insoluble salts) that remain in the reaction
mixture. In some embodiments, the solvent can be removed from the filtrate prior to
g (i.e., the residue can be heated neat).
In further embodiments, the nonpolar solution of the reaction mixture of MF
and a compound of Formula (2) can be filtered prior to heating, the nonpolar solvent
can be removed (e.g., by evaporation), and the heating of the sample can be
performed in a different solvent.
GD43WGE
Ar1 is an electron rich aryl or aryl ring . For example, Arl—H can
be more easily oxidized than benzene. In some embodiments, the moiety Ar1 can be
substituted with at least one substituent having a Hammett op value of less than zero.
For example, the substituent can be chosen from: -(C1-C10)alkyl, 10)haloalkyl,
(C2—C10)alkenyl, (C2—C10)alkynyl, —O—(C1—C10)alkyl, —C(O)—O—(C1—C10)alkyl, aryl, and
heteroaryl. In some embodiments, Ar1 can be:
wherein R1, R2, R3, R4, and R5 are independently Chosen from: H, -(C1-C10)alkyl, -(C1—
C10)haloalkyl, (C2—C10)alkenyl, (C2-C10)alkynyl, —O—(C1—C10)alkyl, —C(O)—O—(C1-
C10)alkyl, aryl, and heteroaryl, or two or more of R1, R2, R3, R4, and R5 come together
to form a fused aryl or heteroaryl ring system.
Ar2 is an aryl or heteroaryl ring system. In some embodiments, Ar2 is Chosen
from a phenylalanine derivative, tyrosine derivative, typtophan tive, histidine
derivative, and estradiol derivative. In some embodiments, Ar2 is chosen from:
M W
OMe CN MeO OMe
Me M
OMe CFs
2012/044954
24742-0043WGE
WO 03734
24742-0043WGE
PL ,P2
N PL ,P2
éops
PL ,P2
O‘P5
PL ,P2
b \E/
PL ,P2
2012/044954
24742-0434SWO:
PL ,P2
3 Aw
P\O \
PLN/
PLO P7—oE j P7-O P7-o
0P3 0P3 J‘L 0P3 0P3
PLN,P2 PLN/P2
P7-O PLO O
‘31? ‘5 \ 0171’
0P3 0P3
0P4 CN
/ /
l l
\ ”<\N\
\ \\
N % N \\ '75
.11; 571/
ON ON
<8 OP3
\N zN
\ \
“‘a, \ a, \x‘
P4—o
CN 0P3 CN
P4_O
J\IW
wherein each of P1, P2 and P6 are independently a nitrogen protecting group, or P1 and
P2 come together to form a single nitrogen protecting group; each of P3, P4, and P7 are
24742-(J043WGE
independently an alcohol ting group, or P3 and P4 come together to form a
single oxygen protecting group; and P5 is a carboxylic acid protecting group.
Also provided herein is a method of making a compound of Formula (6):
wherein each of Pland P2 are independently a nitrogen protecting group, or P1 and P2
come together to form a single nitrogen protecting group; each of P3, and P4 are
independently an alcohol protecting group, or P3 and P4 come together to form a
single oxygen protecting group; and P5 is a carboxylic acid ting group. In one
embodiment, the method includes reacting in a polar solvent a compound MF,
wherein M is a counter ion, and a compound of a (7):
PL ’ P2
r O‘P5
Ar1/I 0
wherein Ar1 is an electron rich aryl or heteroaryl ring system; Y is a leaving group;
and
P1,P2, P3, P4 and P5 are as defined above. Following reaction, the polar solvent can be
removed from the reaction mixture and the remaining mixture can be combined with a
nonpolar t and heated. In another embodiment, a solution sing a
nonpolar solvent, a nd MF, and a compound of Formula (7) can be heated to
provide a compound of Formula (6).
In some embodiments, the nonpolar solution of the reaction e of MF
and a compound of Formula (7) can be filtered prior to heating. The filtration step
can remove any insoluble material (e.g., insoluble salts) that remain in the reaction
mixture. In some embodiments, the solvent can be removed from the filtrate prior to
heating (i.e., the residue can be heated neat).
24742604333705.
In further embodiments, the nonpolar solution of the reaction mixture of MP
and a compound of Formula (7) can be filtered prior to heating, the nonpolar solvent
can be removed (e. g., by evaporation), and the heating of the sample can be
performed in a different solvent.
In the methods described above, Y can be any leaving group, for example, Y
can be, for example, triflate, mesylate, nonaflate, ate, tosylate, nosylate,
ate, perfluoroalkyl sulfonate, tetraphenylborate, hexafluorophosphate,
trifluoroacetate, tetrafluoroborate, perchlorate, roalkylcarboxylate, chloride,
bromide, or iodide.
1O M can vary depending on the nature of the X moiety. In some embodiments,
M can be ium, sodium, , complexes of lithium, sodium, potassium, or
cesium with cryptands or crown ethers, tetrasubstituted ammonium cations, or
phosphonium cations.
The nonpolar solvent used in the methods described herein can be, for
example, e, toluene, 0-xylene, m—xylene, p—xylene, ethyl benzene, carbon
tetrachloride, hexane, cyclohexane, fluorobenzene, chlorobenzene, nitrobenzene, or
mixtures thereof. In some embodiments, the nonpolar solvent comprises benzene. In
some embodiments, the nonpolar solvent comprises toluene.
The polar solvent used in the methods described herein can be, for example,
acetonitrile, acetone, dichloromethane, ethyl acetate, ydrofuran,
dimethylformamide, fluorobenzene, benzotrifluoride or mixtures f.
g of the reaction mixture can include heating at a temperature ranging
from about 25° C to about 250° C. In some embodiments, the heating can occur for
from about 1 second to about 25 minutes. In some embodiments, the heating is
accomplished by a flash sis method, a tional heating method, or by a
microwave method.
24742AGD43WGE
In some embodiments, the compound2of Formula (2) is chosen from:
PL ,P2 PLN,P1 2 N P‘N’P
T O‘P5 O‘P5
Arl/I OAr1/| 0
OP3 Ar1\|
0P4 |
Y OP4
P1\N’PPZ‘N
M57 £7 0%;
wherein each of Pland P2 are independently a nitrogen protecting group, or P1 and P2
come together to form a single nitrogen protecting group; each of P3, and P4 are
independently an alcohol protecting group, or P3 and P4 come er to form a
single oxygen protecting group; and P5 is a carboxylic acid protecting group. For
example, the compound of Formula (2) can be:
PL ,P
T P5
Ar1/| 0
n each of Pland P2 are independently a nitrogen ting group, or P1 and P2
come together to form a single nitrogen protecting group; each of P3, and P4 are
independently an alcohol protecting group, or P3 and P4 come together to form a
single oxygen protecting group; and P5 is a carboxylic acid protecting group. In some
embodiments, the nd of Formula (2) can be:
0 O
t—Bu\OJLNJJ\O/t-Bu
Y ““%O\
NV: 0
2012/044954
24742:0043VVC£
In some embodiments, the compound of Formula (2) can be:
0 O
t_Bu\OJJ\ JL /t-BU
N o
M90O
| 0
In some embodiments, the compound of Formula (2) is chosen from:
O /' /'
\ Y
Y \N \ T N \ '
% i\1 \ \
|\Ar1 I\Ar1
0 Ar
0” CN
3 S
’<\ \ l ’N
Y (x Y / Y
N % N
i % i Q i
\Ar1 \Ar1 \Ar1
CN CN CN
In some embodiments, the compound of Formula (2) is chosen from:
Arl/|
P4—o
P4—o
Y’ \Ar1
wherein each of P3 and P4 are independently an alcohol protecting group.
WO 03734
24742:0043VVC£
In some embodiments, the compound of Formula (1) or Formula (3) is chosen
from:
P1N PL”,
<9$$
(an? :95:
wherein each of P1and P2 are independently a nitrogen protecting group, or P1 and P2
come together to form a single nitrogen protecting group; each of P3, and P4 are
independently an l protecting group, or P3 and P4 come together to form a
single oxygen protecting group; and P5 is a carboxylic acid protecting group.
In some embodiments, the compound of Formula (1) or Formula (3) is chosen
from:
/ /
O I I
N \ \N \
Q§ \\ \\
F F
CN CN
3 S
’4 \ <\N\ /N
N % F % F % F
ON CN
2012/044954
24742A6043WGE
In some embodiments, the nd of Formula (1) or Formula (3) is chosen
from:
Pit—O
P4—o
wherein each of P3 and P4 are independently an alcohol protecting group.
In some embodiments, the compound of a (1) or Formula (3) can be:
P1 P2
F 0
wherein each of Pland P2 are independently a nitrogen protecting group, or P1 and P2
come together to form a single nitrogen protecting group; each of P3, and P4 are
independently an alcohol protecting group, or P3 and P4 come together to form a
single oxygen protecting group; and P5 is a carboxylic acid protecting group. For
example, the compound of Formula (1) or Formula (3) can be:
O 0
t—Bu\OJLNJJ\O/t-Bu
\‘\\K[(O\
F O
In some embodiments, the compound of Formula (1) or Formula (3) can be:
”:2 H2
F O
24742AGD43WGE
In some embodiments, the compound of Formula (7) can be:
0 O
t—Bu\OJLNJJ\O,t-Bu
Y \\“Hro\
Arl/i O
For e, the compound of Formula (7”) can be:
0 O
t-Bu\OJL
MeOO IHZ
T‘fO
In some embodiments, the compound of Formula (6) can be:
0 O
t-BuxoiNJJxO/t-Bu
\‘\\S‘/O\
F O
Also provided herein is a method for making a nd of Formula (1) that
can include heating a mixture sing a nonpolar solvent and a compound of
Formula (5):
wherein Ar1 is an electron rich aryl or heteroaryl ring system; and Ar2 and X are as
defined for Formula (1). In some embodiments, the reaction mixture is filtered (i.e.,
to remove insoluble material) prior to heating. In some embodiments, the reaction
e is filtered and the nonpoloar solvent is removed and the resulting residue is
dissolved in a polar solvent prior to heating. In some embodiments, X is F (e.g., 18F).
WO 03734
24742AGD43WGE
Also provided herein is a method for making a compound of Formula (3) that
can include heating a mixture comprising a nonpolar solvent and a compound of
Formula (4):
wherein Ar1 is an electron rich aryl or heteroaryl ring system; and Ar2 is as defined for
Formula (3). In some embodiments, the reaction mixture is filtered (i.e., to remove
insoluble material) prior to heating. In some embodiments, the reaction mixture is
d and the nonpoloar t is removed and the resulting residue is dissolved in
a polar solvent prior to heating.
Further provided herein is a compound of Formula (8):
wherein Ar1 is an electron rich aryl or heteroaryl ring system; each of Pland P2 are
independently a nitrogen protecting group, or P1 and P2 come together to form a
single nitrogen protecting group; each of P3, and P4 are independently an alcohol
ting group, or P3 and P4 come together to form a single oxygen protecting
group; and
P5 is a carboxylic acid protecting group. In some embodiments, the compound of
Formula (8) is:
O O
t—Bu\OJLNJJ\O,t-Bu
F \\\‘K[ro\
Ar“: 0
24’242AGD43WGE
In some embodiments, the compound of Formula (8) is:
0 0
M60O 5
,' 0
A compound of Formula (6) is also provided. The nd can be prepared
using any of the methods described herein.
The details of one or more embodiments of the invention are set forth in the
accompanying drawings and the description below. Other features, objects, and
advantages of the invention will be apparent from the description and drawings, and
from the claims.
DESCRIPTION OF GS
shows the decomposition of MTEB-I-F in acetonitrile at 90 °C.
shows the decomposition of MTEB-I-F in e at 90 °C.
details the 1H NMR of 6-Fluoro-L-DOPA
details the ”P NMR of 6-Fluoro-L-DOPA.
DETAILED DESCRIPTION
Definitions
Unless defined otherwise, all technical and scientific terms used herein have
the same g as is commonly understood by one of ordinary skill in the art to
which this disclosure belongs. All s, applications, published applications, and
other publications are incorporated by reference in their entirety. In the event that
there is a plurality of definitions for a term herein, those in this section l unless
stated otherwise.
As used herein, the singular forms “a,” “an,” and “the” e plural referents
unless the context clearly es otherwise.
In general, the term “aryl” includes groups having 5 to 14 carbon atoms which
form a ring structure and have an aromatic character, including 5- and 6—membered
single-ring aromatic groups, such as benzene and . Furthermore, the term
“aryl” includes polycyclic aryl groups, e.g., tricyclic, bicyclic, such as naphthalene
and anthracene.
GD43W01
The term “heteroaryl” includes groups having 5 to 14 atoms which form a ring
structure and have an aromatic character, including 5- and 6-membered single-ring
aromatic groups, that have from one to four heteroatoms, for example, pyrrole, furan,
thiophene, thiazole, isothiaozole, imidazole, triazole, tetrazole, pyrazole, oxazole,
isooxazole, pyridine, pyrazine, pyridazine, and dine, and the like. Furthermore,
the term “heteroaryl” includes polycyclic heteroaryl groups, e.g., lic, ic,
such as benzoxazole, benzodioxazole, benzothiazole, benzoimidazole,
benzothiophene, methylenedioxyphenyl, ine, isoquinoline, napthridine, indole,
uran, purine, benzofuran, deazapurine, indazole, or indolizine.
1O The term “substituted” means that an atom or group of atoms formally
replaces hydrogen as a “substituent” attached to another group. For aryl and
heteroaryl , the term “substituted”, unless otherwise indicated, refers to any
level of substitution, namely mono, di, tri, tetra, or penta substitution, where such
substitution is permitted. The tuents are independently ed, and
substitution may be at any chemically accessible position.
The compounds provided herein may encompass various stereochemical forms
and tautomers. The compounds also encompasses diastereomers as well as optical
isomers, e. g. mixtures of enantiomers including racemic mixtures, as well as
individual enantiomers and diastereomers, which arise as a consequence of structural
asymmetry in certain compounds. Separation of the individual s or selective
synthesis of the individual s is accomplished by application of various methods
which are well known to practitioners in the art.
The term “electron rich”, as used herein, refers to an aryl or heteroaryl ring
system which is more easily ed than benzene. For example the aryl or
heteroaryl ring system may be substituted with one or more substituents having a
Hammett op value of less than zero.
The term “fluorine” unless itly stated ise includes all fluorine
isotopes. Multiple fluorine isotopes are known, however, only 19F is stable. The
radioisotope 18F has a half-life of 109.8 minutes and emits positrons during
radioactive decay. The relative amount of 18F t at a designated site in a
compound of this disclosure will depend upon a number of factors including the
isotopic purity of 18F labeled reagents used to make the compound, the efficiency of
incorporation of 18F in the various synthesis steps used to prepare the compound, and
the length of time since the 18F has been produced. When a position is designated
specifically as 18F in the methods and compounds of the present disclosure, the
24742004333705.
position is understood to have at least about 0.01%, at least about 0.1%, at least about
1%, at least about 2%, at least about 3%, at least about 4%, at least about 5%, at least
about 10%, at least about 15%, at least about 20%, at least about 25%, at least about
%, at least about 35%, at least about 45%, at least about 50%, at least about 55%, at
least about 60%, at least about 65%, at least about 70%, at least about 75%, at least
about 80%, or at least about 85% 18F incorporation at that site.
Methods ofPreparing Substituted Aryl and Heteroaryl Ring Systems
Provided herein are methods of preparing substituted aryl and heteroaryl ring
1O systems using iodonium compounds and intermediates. For example,
diaryliodonium salts and diaryliodonium fluorides, as provided herein, can undergo
decomposition to prepare an aryl fluoride.
For example, provided herein is a method for making a compound of Formula
(1):
ArZ—X
wherein Ar2 is an aryl or heteroaryl ring system; and X is a moiety wherein the pKa of
the acid H-X is less than 12. In some ments, a nd of Formula (1) can
be prepared as shown in Scheme 1.
Scheme 1.
Y X
I M
Ar1—I—Ar2 —X> Ar2 —> x—Ar2
2 1
In some embodiments, the method can include reacting in a polar solvent a
nd MX, n M is a counter ion and X is as defined in Formula (1), and a
compound of Formula (2):
wherein Ar1 is an electron rich aryl or heteroaryl ring ; Y is a leaving group;
and Ar2 and X are as defined above in Formula (1). The polar solvent can then be
d from the reaction mixture. The remaining mixture can then be combined
with a nonpolar solvent and heated to produce a compound of Formula (1).
In some embodiments, the method can include heating a mixture comprising a
nonpolar solvent, a compound MX, and a compound of Formula (2).
24742-04MSWGE
In some embodiments, the nonpolar solution of the reaction mixture ofMX
andacompmmdomenmhtZanbefihmedpfimflohmumg.ThefihmfimimQ)
can remove any insoluble material (e.g., insoluble salts) that remain in the reaction
mixture. In some embodiments, the t can be removed from the filtrate prior to
heating (i.e., the residue can be heated neat).
In further embodiments, the nonpolar solution of the reaction mixture of MX
and a compound of Formula (2) can be ed prior to heating, the nonpolar solvent
can be removed (e.g., by evaporation), and the heating of the sample can be
performed in a different solvent.
1O In some embodiments, contaminant salts are removed from the solution of the
reaction mixture ofMX and a compound of Formula (2) in the polar or nonpolar
solution by chromatography. For e, the inant salts can be removed by
size exclusion, gel filtration, reverse phase, or other chromatographic method prior to
heating.
Substituted aryls and heteroaryls which are prepared using the methods
described herein can have an X moiety which includes any moiety in which the pKa
of H-X (i.e., the conjugate acid of X) is less than about 12. In some cases, X is a
radioactive isotope (e. g., 18F, 123’I, 1311, and compounds having 32F and 3"2’P). In some
embodiments, X can be chosen from halide, aryl carboxylate, alkyl carboxylate,
phosphate, phosphonate, phosphonite, azide, anate, cyanate, phenoxide, triflate,
trifluoroethoxide, thiolates, and stabilized es. For example, X can be fluoride,
chloride, bromide, iodide, trifluoroacetate, benzoate, and acetate. In some
ments, X is fluoride. In some embodiments, is a ctive isotope of
fluoride (e. g., 18F).
chbemywmmbbwmggmm.Msmmemmflmwm&YmawwMy
nating anion (i.e., an anion that coordinates only weakly with iodine). For
example, Y can be the conjugate base of a strong acid, for example, any anion for
which the pKa of the conjugate acid (H—Y) is less than about 1. For example, Y can
be triflate, mesylate, nonaflate, hexaflate, toluene sulfonate (tosylate), nitrophenyl
sulfonate (nosylate), bromophenyl sulfonate (brosylate), perfluoroalkyl sulfonate
(e.g., perfluoro C240 alkyl ate), henylborate, hexafluorophosphate,
trifluoroacetate, perfluoroalkylcarboxylate, tetrafluoroborate, perchlorate,
hexafluorostibate, hexachlorostibate, chloride, bromide, or iodide. In some
embodiments, a slightly more basic g group such as acetate or benzoate may be
used.
24742AGG43WGE
The counter ion M can be any suitable cation for the d X. The choice of
the source of X, and accordingly M, is readily within the dge of one of
ordinary skill in the art. For example, M can be chosen from an alkali metal, alkaline
earth metal and transition metal salts such as, for example, calcium, magnesium,
potassium, sodium and zinc salts. Metal cations may also be complexed to cryptands
or crown ethers to enhance their solubility and to labilize the X moiety. M can also
include organic salts made from quaternized amines derived from, for example, N,N'
dibenzylethylenediamine, chloroprocaine, choline, diethanolamine, ethylenediamine,
meglumine hylglucamine) and procaine. In some ments, M can be a
lithium, sodium, potassium, or cesium with cryptands or crown ethers, a
tetrasubstituted ammonium cation, or phosphonium cation. When X is fluoride, the
choice of fluoride source is also readily within the knowledge of one of ordinary skill
in the art. A variety of fluoride sources can be used in the ation of the
fluorinated aryl and heteroaryl compounds as provided herein, including but not
d to NaF, KF, CsF, tetrabutylammonium fluoride, and tetramethylammonium
fluoride. In certain instances the choice of fluoride source will depend on the
functionality present on the compound of Formula (2).
The methods described above can be useful in the preparation of fluorinated
aryl and heteroaryl ring systems. For example, the methods can be used to prepare a
compound of Formula (3):
ArZ—F
wherein Ar2 is an aryl or aryl ring system. In particular, the methods can be
used to prepare radiolabeled fluorinated aryl and heteroaryl ring systems (e. g., PET
radiotracers). In some embodiments, the method can include reacting in a polar
solvent a nd MF and a compound of Formula (2). The polar solvent can then
be d from the on mixture. The remaining mixture can then be combined
with a nonpolar t and heated to produce a nd of Formula (3).
In some embodiments, the method can include heating a mixture comprising a
nonpolar solvent, a compound MF, and a compound of Formula (2).
In some embodiments, the nonpolar solution of the reaction mixture of MF
and a compound of Formula (2) can be d prior to heating. The filtration step
can remove any insoluble material (e.g., insoluble salts) that remain in the on
mixture. In some embodiments, the solvent can be removed from the filtrate prior to
heating (i.e., the residue can be heated neat).
24'}42-(}4)43V»"Gi
In some embodiments, the nonpolar solution of the reaction mixture of MF
and a compound of Formula (2) can be filtered prior to heating, the nonpolar t
can be removed (e. g., by evaporation), and the heating of the sample can be
performed in a different t.
In some embodiments, contaminant salts are removed from the nonpolar
solution of the reaction mixture of MF and a compound of Formula (2) by
chromatography. For example, the contaminant salts can be removed by size
exclusion, gel filtration, reverse phase, or other chromatographic method prior to
heating.
1O In some embodiments, the compound of Formula (3) can be a compound of
Formula (6):
PL ,P2
wherein each of Pland P2 are independently a nitrogen protecting group, or P1 and P2
come together to form a single nitrogen protecting group; each of P3, and P4 are
ndently an l protecting group, or P3 and P4 come together to form a
single oxygen protecting group; and P5 is a carboxylic acid protecting group. In some
embodiments, the method can include reacting in a polar solvent a compound MF and
a compound of Formula (7):
PL ,P2
Y 0*”
AH/I 0
0P4
wherein Ar1 is an electron rich aryl or heteroaryl ring system; Y is a leaving group;
and P1,P2, P3, P4 and P5 are as defined in Formula (6). The polar solvent can then be
removed from the reaction mixture. The remaining mixture can then be combined
with a nonpolar solvent and heated to produce a compound of a (6).
In some ments, the method can e g a mixture comprising a
nonpolar t, a compound MF, and a compound of Formula (7).
24742aflfl43VVCfi
In some embodiments, the nonpolar solution of the reaction mixture of MF
and a compound of Formula (7) can be filtered prior to heating. The filtration step
can remove any insoluble material (e.g., insoluble salts) that remain in the on
mixture. In some embodiments, the solvent can be removed from the filtrate prior to
heating (i.e., the e can be heated neat).
In some embodiments, contaminant salts are removed from the nonpolar
solution of the reaction mixture of MF and a compound of Formula (7) by
chromatography. For e, the contaminant salts can be removed by size
exclusion, gel filtration, e phase, or other chromatographic method prior to
1O heating.
The compound of Formula (6) can be, for example,
P1 P2
F 0
In some embodiments, the compound of Formula (6) is:
O O
t—Bu\ JL A /t-Bu
O N O
24742AGD43WGE
In some embodiments, the compound of Formula (7) can be:
0 O
t—Bu\OJLNJJ\O,t-Bu
Y \\“Hro\
Ar1/i O
In some embodiments, the compound of a (7) can be:
0 O
t-Bu\OJL
N -BU
MeOO
I O
T‘fO
The moiety Ar1 can be an electron—rich aryl or heteroaryl ring system. For
example, in some embodiments, Arl—H is more easily oxidized than benzene. In
some embodiments, Ar1 can be substituted with at least one substituent having a
Hammett op value of less than zero (see, for example, “A survey of Hammett
substituent constants and resonance and field parameters”, Corwin. Hansch, A. Leo,
R. W. Taft Chem. Rev., 1991, 91 (2), pp 165—195). For example, Ar1 can be
substituted with at least one of —(C1—C10)alkyl, —(C1-C10)haloalkyl, 0)alkenyl,
o)alkynyl, —O—(C1—C10)alkyl, —C(O)—O—(C1-C10)alkyl, aryl, and heteroaryl. In
some embodiments, Ar1 is:
wherein R1, R2, R3, R4, and R5 are independently chosen from: H, -(C1-C10)alkyl, -(C1—
C10)haloalkyl, (C2—C10)alkenyl, (C2—C10)alkynyl, —O—(C1—C10)alkyl, —C(O)—O—(C1—
kyl, aryl, and heteroaryl, or two or more of R1, R2, R3, R4, and R5 come together
to form a fused aryl or heteroaryl ring system.
In some embodiments, Ar1 is the same as Arz. In some embodiments, Ar1 is
more easily oxidized than Arz.
In some embodiments, Ar1 can be substituted with a solid support. A “solid
support” may be any suitable solid—phase support which is insoluble in any solvents to
24742.4)043‘93781
be used in the process but which can be covalently bound (e.g., to Ar1 or to an
optional linker). Examples of suitable solid supports include polymers such as
polystyrene (which may be block d, for example with polyethylene glycol),
polyacrylamide, or polypropylene or glass or silicon coated with such a polymer. The
solid t may be in the form of small discrete particles such as beads or pins, or
as a coating on the inner e of a reaction vessel, for example a cartridge or a
microfabricated . See, for example, US. Patent Application No. 2007/0092441.
In some embodiments, the solid support is covalently bound to Ar1 through the
use of a linker. A “linker” can be any suitable organic group which serves to space the
1O Ar1 from the solid support structure so as to maximize reactivity. For example, a
linker can include a C1_20 alkyl or a C120 alkoxy, attached to the solid support, for
example, a resin by an amide ether or a sulphonamide bond for ease of synthesis. The
linker may also be a polyethylene glycol (PEG) . Examples of such linkers are
well known to those skilled in the art of solid—phase chemistry.
The methods described herein can be used with a variety of aryl and heteroaryl
ring systems. As is well understood by one of skill in the art, to carry out efficient
nucleophilic substitution of the aryl and heteroaryl ring s described herein, it is
necessary that Ar1 be more easily ed (i.e., more electron rich) than Arz. Within
that boundary, however, the Ar2 moiety can be any aryl or heteroaryl ring system in
which substitution by X (e. g., F such as 18F) is desired. For example, Ar2 can be a
phenylalanine, tyrosine, typtophan, or histidine tive, and an estradiol derivative.
In some embodiments, Ar2 can be chosen from:
OMe CN MeO OMe
Me MN
OMe CFs
WO 03734
24742-0043WGE
}4)43W01
P1 P2
‘N ’ P \N,P1 2 PL , P2
O‘P5 0‘P5
9“ 0 ”\w 0
\ 34/ \
N N
\P6 \P6
PLN’PZ PLN’PZ P’LN’PZ
P5 0‘
P5 0\
0 O O
‘5 \ \
N N
‘P6 3% \PS N‘ps
""‘\N
P1\ l P2 PLN’PZ PLN’PZ
45‘"
N N\ N\
\PB P6 P6
PLN’PZ P1\N,P2 PLN/Pz
fl: \ \
N N
‘PB N‘
“a ‘P6 6
/ P
.M’"
24742434343wo:
PL [P2 P1 P2 P1 P2
N \N/ \N/
\ \ \ \ \ \
O o o
N\ N N
6 ‘ ‘
P 6 6
”h P P
PL / p1 1 2
N \N'P2 p1 [p2
N P\N’P
P —07 pkg P7—0 P7-o
0P3 0P3 3‘; 0P3 0P3
OP4 ”.W
P\N,P1 2 PL ,P2
N o
‘31? ‘5 \ 0177:
0P3 0P3
0P4 CN
<\ \
N \\ is:
P4_O
P4_O
J\IW
wherein each of P1, P2 and P6 are independently a nitrogen protecting group, or P1 and
P2 come together to form a single en protecting group; and each of P3, P4, P5 and
P7 are independently an oxygen protecting group, or P3 and P4 come together to form
2012/044954
24742AGQ43WOE
a single oxygen ting group. In some ments, Ar2 is an electron rich aryl
or heteroaryl ring system.
Protecting groups can be a temporary substituent which protects a ially
reactive functional group from undesired chemical transformations. The choice of the
particular protecting group employed is well within the skill of one of ordinary skill in
the art. A number of considerations can determine the choice of protecting group
including, but not limited to, the functional group being protected, other functionality
present in the molecule, on conditions at each step of the synthetic ce,
other protecting groups present in the molecule, functional group tolerance to
1O conditions required to remove the protecting group, and reaction conditions for the
thermal decomposition of the compounds provided herein. The field of protecting
group chemistry has been reviewed (Greene, T. W.; Wuts, P. G. M. Protective Groups
in Organic Synthesis, 2.sup.nd ed.; Wiley: New York, 1991).
A nitrogen protecting group can be any temporary substituent which protects
an amine moiety from undesired chemical transformations. Examples of such
protecting groups e, but are not limited to allylamine, benzylamines (e.g.,
bezylamine, p-methoxybenzylamine, 2,4-dimethoxybenzylamine, and tritylamine),
acetylamide, trichloroacetammide, trifluoroacetamide, pentenamide, phthalimides,
carbamates (e.g., methyl carbamate, t-butyl carbamate, benzyl carbamate, allyl
carbamates, 2,2,2-trichloroethyl carbamate, and enylmethyl carbamate),
imines, and amides (e. g., benzene sulfonamide, p-toluenesulfonamide, and p—
nitrobenzenesulfonamide).
An oxygen protecting group can be any temporary substituent which protects a
hydroxyl moiety from undesired al ormations. Examples of such
protecting groups include, but are not limited to esters (e.g., acetyl, t—butyl carbonyl,
and benzoyl), benzyl (e. g., benzyl, p-methoxybenzyl, and 2,4-dimethoxybenzyl, and
trityl), ates (e. g., methyl carbonate, allyl carbonate, 2,2,2-trichloroethyl
carbonate and benzyl carbonate) ketals, and acetals, and ethers.
24742412433705.
In some embodiments, a compound of Formula (2), as provided herein, can be
chosen from:
PLN,P2 PLN,P2 PLNlpz
O\ 0‘
T P5 P5 0‘
T P5
/| 0 /| O
Ar1 Ar1 0
OP3 Ark
OP4 0P4 4/ OP4
P1\N,P2 PLN,P2 P2\N’P1
/| O O O
Ar1 |\Ar1
0P3 OP3 0P3
Y/kAH
wherein:
each of Pland P2 are ndently a nitrogen protecting group, or P1 and P2 come
together to form a single nitrogen protecting group;
each of P3 and P4 are independently an oxygen protecting group, or P3 and P4 come
er to form a single oxygen protecting group, and P5 is a carboxylic acid
protecting group. For example, a compound of Formula (2) can be:
PL ,P2
T P5
Ar1/I 0
In some embodiments, a nd of Formula (2) can be:
t-Bu\ i i -Bu
0 N CA
1 \“‘S(O\
Arl/I O
24742:0043VVC£
In some embodiments, a compound of Formula (2) can be:
0 O
t'Bu\OJJ\NJJ\O/t-Bu
M90O E
| O
In some embodiments, a nd of Formula (2) is chosen from:
/ /
O I I
\ Y \ Y
Y N \ I N Q '
% l\ \ |\Ar1 |\Ar1
0 Ar1
ON CN
3 S RN
’—<\N \ \ ’N
Y /
| <\N \ Y
\ \ T
\ |\Ar1 \ |\Ar1 \ |\Ar1
ON ON ON
In other embodiments, a compound of Formula (2) is chosen from:
Ar1/|
P4—o
P4-o
Y/ \Ar1
wherein:
each of P3 and P4 are independently an alcohol protecting group.
247424M43WG1
In some embodiments, a compound of Formula (1) or Formula (3) can be
chosen from:
P1N PLN ,P
ISCWélLSW
(an? :95:
wherein each of P1and P2 are independently a nitrogen protecting group, or P1 and P2
come together to form a single en protecting group; and each of P3 and P4 are
independently an alcohol protecting group, or P3 and P4 come together to form a
single oxygen protecting group, and P5 is a carboxylic acid protecting group. For
examples, a compound of Formula (1) or Formula (3) can be:
P ,P2
o\P5
F 0
In some embodiments, a nd of Formula (1) or Formula (3) can be:
t—Bu\OJOL ftN O,t—Bu
\\‘\S(O\
F O
24742aflfl43VVCfi
In some embodiments, a compound of Formula (1) or Formula (3) can be:
[“2 H2
F O
In some embodiments, a compound of Formula (1) or Formula (3) can be
chosen from:
Q Q F F
ON CN
S
’4 \ <\N \ ,N
N % F § F % F
ON ON ON
In some embodiments, a compound of Formula (1) or Formula (3) is chosen
from:
Pit—O
P4—o
F
wherein each of P3 and P4 are independently an alcohol protecting group.
A nonpolar solvent can be any solvent having a dielectric constant of less than
about 10. For example, a nonpolar solvent can be chosen from e, toluene, 0—
xylene, m-xylene, p-xylene, ethyl benzene, carbon tetrachloride, hexane, cyclohexane,
enzene, chlorobenzene, nitrobenzene, and mixtures f. In some
embodiments, the nonpolar solvent ses benzene. In some embodiments, the
nonpolar solvent comprises toluene. In some embodiments, the ar solvent
WO 03734
24742004333105.
ses cyclohexane. In some embodiments the nonpolar solvent is a mixture, for
example a mixture of exane and toluene.
A polar solvent is a solvent having a dielectric constant greater than about 10.
In some embodiments, the polar solvent is a polar aprotic solvent, such as acetonitrile,
acetone, dichloromethane, ethyl acetate, tetrahydrofuran, dimethylformamide, 1,2-
difluorobenzene, benzotrifluoride, and mixtures thereof. In some embodiments, the
polar c solvent is acetonitrile.
Heating can be accomplished by conventional means (e. g., heating bath, oven,
heat gun, hot plate, Bunsen , heating mantle, and the like), by the use of a
ave, or by flash pyrolysis. Typically, the reaction mixture is heated at a
temperature ranging from about 25° C to about 250° C (e. g., between about 80° C to
about 200° C, 100° C to about 200° C, about 120° C to about 170° C, about 120° C to
about 160° C, about 120° C to about 150° C, and about 130° C to about 150° C). In
some embodiments, the reaction mixture is heated to about 140 °C. Heating can
occur for any time necessary to complete the reaction. For example, g can
occur for from about 1 second to about 25 s (e.g., about 2 seconds, about 5
seconds, about 10 seconds, about 30 seconds, about 1 minute, about 90 s, about
2 minutes, about 3 minutes, about 5 minutes, about 8 minutes, about 10 minutes,
about 12 minutes, about 15 minutes, about 20 minutes, and about 24 minutes). In
some embodiments, heating can occur for from about 1 second to about 15 minutes.
Further provided herein is a method of making a compound of Formula (1)
that includes heating a mixture comprising a nonpolar solvent and a compound of
Formula (5):
wherein Ar1 is an electron rich aryl or heteroaryl ring system; and Ar2 and X are as
defined for Formula (1). In some embodiments, the method can include filtering the
mixture prior to heating. Filtering, as described above, can remove insoluble
materials such as insoluble salts. In another embodiment, the method can include,
prior to heating, filtering the mixture, removing the nonpolar solvent, and
subsequently g a solution of the remaining reaction e and a polar t.
In some embodiments, contaminant salts are removed from the nonpolar
solution of a compound of Formula (5) by chromatography. For example, the
24742AGG43WGE
contaminant salts can be removed by size exclusion, gel filtration, e phase, or
other chromatographic method prior to heating.
As described above, the methods described herein can be used to prepare
ated (e. g., 18F) aryl and heteroaryl ring systems. Accordingly, further provided
herein is a method for making a compound of Formula (3) that includes heating a
mixture comprising a nonpolar t and a compound of Formula (4):
Ar1—I:
n Ar1 is an electron rich aryl or heteroaryl ring system; and Ar2 is as defined for
Formula (3). In some embodiments, the method can include filtering the mixture
prior to heating. Filtering, as bed above, can remove insoluble materials such as
insoluble salts. In another embodiment, the method can include, prior to heating,
filtering the mixture, removing the nonpolar solvent, and subsequently heating a
solution of the remaining reaction mixture and a polar solvent.
In some embodiments, contaminant salts are removed from the nonpolar
solution a nd of Formula (4) by chromatography. In some embodiments, a
relatively mild chromatographic desalting technique is used. For example, size
exclusion chromatography (also referred to as gel ion) can provide a reliable
means to separate diaryliodonium salts from the contaminating inorganic (e.g.,
sodium or potassium carbonate, bicarbonate, hydroxide, or triflate) or organic (e.g.,
tetraalkylammonium, cryptand complexes of alkalai metal ions) salts that can
contaminate radiochemical ations. Removal of these contaminant salts can
assist in increasing the yield of the uorination of this substrate class.
In the methods described herein, a pressure tube or other reinforced closed
system can be used in instances where the desired temperature is above the boiling
point of the solvent utilized.
The reaction can be conducted in the presence of an inert gas such as en
or argon. In some embodiments, steps are taken to remove oxygen and/or water from
the reaction solvent and starting materials. This can be accomplished by a number of
s including distillation of solvents in the ce of agents that react with
and/or sequester water and under an atmosphere of inert gas; and purging the reaction
vessel with an inert gas.
The methods described herein can be used when MX (e. g., MP) is reacted in
an amount g from about 1 picomole to about 10 millimoles (e.g., about 1
GD43WGE
picomole to about 5 oles; about 1 le to about 1 millimole; about 1
picomole to about 500 micromoles; about 1 picomole to about 100 micromoles; about
1 picomole to about 50 micromoles; about 1 picomole to about 5 micromoles; about 1
picomole to about 1 micromole; about 1 picomole to about 500 les; about 1
picomole to about 100 nanomoles; about 1 picomole to about 50 nanomoles; about 1
picomole to about 5 nanomoles; about 1 picomole to about 1 nanomole; about 100
picomoles to about 10 millimoles; about 500 picomoles to about 10 millimoles; about
1 nanomole to about 10 oles; about 50 nanomoles to about 10 millimoles; about
100 nanomoles to about 10 millimoles; about 500 nanomoles to about 10 millimoles;
about 1 micromole to about 10 millimoles; about 50 micromoles to about 10
millimoles; about 100 oles to about 10 millimoles; about 500 micromoles to
about 10 millimoles and about 1 millimole to about 10 millimoles). In some
embodiments, MX is reacted in the sample in an amount of less than about 10
millimoles. In many cases, the compound of Formula (2) is used in an excess when
compared to the amount of MX present in the sample. In some embodiments, the
reaction mixture having MX further contains additional compounds which may be
present in an excess compared to MX. For example, the onal compounds may
be present in more than one n fold excess compared to MX.
Compounds
Diaryliodonium compounds, for example, compound of Formula (2), (4), (7)
and (8), are further provided . For example, a compound of Formula (8) is
provided,
wherein Ar1 is an electron rich aryl or heteroaryl ring system; each of Pland P2 are
independently a nitrogen protecting group, or P1 and P2 come together to form a
single nitrogen protecting group; each of P3, and P4 are ndently an alcohol
protecting group, or P3 and P4 come together to form a single oxygen protecting
247424fl343WGi
group; and P5 is a carboxylic acid ting group. In some embodiments, the
compound of Formula (8) can be:
0 O
t-BU\OJLNJJ\O/t_Bu
M600 5
1' 0
The diaryliodonium compounds of Formula (2), (4) and (7) can be prepared
from commercially available starting materials using various methods known to those
of ordinary skill in the art. The method used for synthesizing the compounds will
depend on the electronics and functionality present in ofArz. Potentially reactive
onal groups present in Ar2 can be masked using a protecting group prior to the
synthesis of the iodonium compound. The particular method employed for
preparing the diaryliodonium nds will be readily apparent to a person of
ordinary skill in the art. For example, the compounds can be made using the
following generic reactions as shown in Scheme 2.
24742.4)043‘93701
Scheme 2.
r r
Arl—I + HY
+ Ar2-H —..> Ar1—I—Ar2
| COHdItIOhS
Y T
Arl—H + Arz—I —..> Ar1—I—Ar2 + HY
| ions
r r
Arl—I + W
+ Ar2-M —..> Ar1—I—Ar2
I COHdItIOflS
r r
Arl—M + Arz—l —> Ar1—I—Ar2 + W
| conditions
For compounds that bear sensitive functionality on the accepting group,
organometallic reagents that e more covalent (more ) C—M bonds can be
used. For example, organometallic compounds including tin, boron, and zinc. If there
is no functional group incompatibility, more basic organometallic reagents
(organolithium, Grignard, etc.) can be used to prepare the diaryliodonium salts.
Persons skilled in the art will be aware of variations of, and alternatives to, the
processes described which allow the compounds defined herein to be obtained.
It will also be appreciated by s skilled in the art that, within certain of
the processes described, the order of the synthetic steps ed may be varied and
will depend inter alia on s such as the nature of other functional groups present
in a ular substrate, the availability of key intermediates, and the protecting group
strategy (if any) to be adopted. Clearly, such factors will also influence the choice of
reagent for use in the said synthetic steps.
The skilled person will appreciate that the diaryliodonium compounds
described could be made by methods other than those herein described, by adaptation
of the methods herein described and/or tion of methods known in the art, for
example US 2007/0092441, or using standard textbooks such as "Comprehensive
Organic Transformations--A Guide to Functional Group Transformations", R C
Larock, Wiley—VCH (1999 or later editions) and Science of Synthesis, Volume 3 la,
2007 n—Weyl, Thieme)
It is to be understood that the synthetic transformation methods mentioned
herein are exemplary only and they may be carried out in various different sequences
in order that the desired compounds can be efficiently assembled. The skilled chemist
24'}424}043W01
will exercise his judgment and skill as to the most efficient sequence of reactions for
synthesis of a given target compound.
As exemplified in the examples below, certain diaryliodonium es can
be ed by H2SO4 zed electrophilic aromatic substitution of the aromatic
fluorine precursor with ArI(OAc)2, ed by ion exchange. The desired
diaryliodonium fluoride is formed by reacting the resulting diaryliodonium salt with a
fluoride source, such as tetrabutylammonium fluoride, as illustrated in Scheme 3
shown below.
Scheme 3.
1. ArI(OAc)2 x9
Catalytic H2804
2. IonExchange/[j/fiB\© TBAF F\©
R —I;II/©/
Diaryliodonium fluorides can also be prepared by the reaction of the
corresponding tributylstannanyl derivative of the aromatic fluorine precursor with p-
MeOPhI(OH)(OTs), ed by ion exchange, and reaction of the resulting
diaryliodonium salt with a fluoride source, such as tetrabutylammonium fluoride, as
illustrated in Scheme 4.
Scheme 4.
1. p-(MeOPh| OH)()(OAc) '7
ROSH(BU)—>3 2. Ion Exchange ROI00mTBAF ROIOOMe
The choice of fluoride source is readily within the knowledge of one of
ordinary skill in the art. A variety of fluoride sources can be used in the preparation of
the diaryliodonium fluorides as provided herein, including but not limited to NaF, KF,
CsF, tetrabutylammonium e, and tetramethylammonium fluoride. In certain
instances the choice of fluoride source will depend on the functionality present on the
ic fluoride precursor.
r ed are compounds of Formula (1) and a (3) which are
prepared by the methods described herein. For e, a compound of Formula (6)
is provided, wherein the compound is prepared as described above.
Also provided herein are kits and devices. Typically, a kit or device is used to
prepare and/or administer a compound of Formula (1) or Formula (3) as provided
04)43V\fۤi
herein. In some ments, the kit or device is used to e a compound of
Formula (1) or Formula (3) and incorporates a chromatographic desalting step prior to
heating the eluted solution comprising the on product of MX and a compound of
Formula (2). In some embodiments, a kit or device can include one or more delivery
systems, e. g., for a nd of Formula (1) or Formula (3), and directions for use of
the kit (e.g., instructions for administering to a subject). In some embodiments, the
kit or device can include a compound of Formula (1) or Formula (3) and a label that
indicates that the ts are to be administered to a subject prior to PET imaging.
1O EXAMPLES
General Methods.
Tetramethylammonium fluoride (TMAF, Aldrich) and diphenyliodonium
nitrate were dried at 60-80° C in a drying pistol (charged with P205) under dynamic
vacuum for one week. Hexabutylditin and tributyltin chloride (Aldrich) were distilled
into flame—dried storage tubes under dry nitrogen. Acetonitrile and acetonitrile-d3
were refluxed with P205, benzene and benzene-d6 were refluxed with CaHz, overnight
and distilled directly into flame-dried storage tubes under dry nitrogen. All glassware,
es, and NMR tubes were oven dried (140° C) for more than 24 hours before
they were transferred into the glove box for use. All other reagents were purchased
from commercial sources and were used as received. All NMR experiments were
performed using a Bruker Avance 400 MHz NMR spectrometer.
Example I - Preparation ofp-methoxyphenyfiodoniam diacetate
p-methoxyphenyliodonium diacetate: 2.34 g (10 mmol) p—iodoanisole was
dissolved in 90 mL of glacial acetic acid. The solution was stirred, heated to 40° C
and 13.6 g (110 mmol) sodium perborate tetrahydrate was added gradually over an
hour. The reaction mixture was kept at 40° C for 8 hours before being cooled to room
temperature. Half of the acetic acid (~45 mL) was removed and 100 mL of DI. water
was added. 3 X 40 mL romethane was used to t the aqueous solution.
The combined organic layers were dried over sodium sulfate and solvent was
evaporated to give 2.25 g (64%) of p—methoxyiodonium diacetate, which was dried in
vacuo and used without r purification. o-methoxyphenyliodonium diacetate
(65%), m—cyanohenyliodonium diacetate (70%), m—trifluoromethyliodnium ate
(80%), and 2,6—dimethoxyphenyliodoniu diacetate (83%) were synthesized using a
similar procedure from corresponding iodoarenes.
04333701
Example 2 - Preparation ofbism-methoxyphenyl)iodoniam triflaoroacetate
Bis(p-methoxyphenyl)iodonium trifluoroacetate: Under N2 protection, 1.41 g
(4 mmol) p—methoxyphenyliodonium diacetate was dissolved in 30 mL of dry
dichloromethane and the solution was cooled to —30° C. 0.61 mL (8 mmol) of
trifluoroacetic acid was added and the solution was slowly brought back to room
temperature and stirred for 30 minutes. The on was, again, cooled to —30° C and
0.44 mL (4 mmol) anisole was added slowly and the mixture was warmed back up to
room temperature and d for 1 hour. The solvent was evaporated and the residual
solid was tallized from diethylether/dichloromethane to give 1.53 g bis(p—
1O methoxyphenyl)iodonium trifluoroacetate (71%).
Example 3 - Preparation ofBiSQD-methoxyphenyl)iodonz'am tosylate
Bis(p—methoxyphenyl)iodonium tosylate: Under N2 protection, 352 mg (1
mmol) p—methoxyphenyliodonium diacetate was dissolved in 1.5 mL of dry
itrile. The solution was combined with a solution of 190 mg (1 mmol)tosy1ic
acid monohydrate in 1.5 mL of dry acetonitrile. After addition of 0.11 mL (1 mmol)
p-iodoanisole, the mixture was allowed to react at room temperature for 2 hours. The
t was then removed and the remaining solid was recrystallized from
diethylether/dichloromethane to give 422 mg bis(p-methoxyphenyl)iodonium tosylate
(82%).
Example 4 - Preparation ofBisay—methoxyphenyl)iodoniam hexaflaorophosphate
Bis(p—methoxyphenyl)iodonium hexafluorophosphate: Under N2 protection,
352 mg (1 mmol) p-methoxyphenyliodonium diacetate was dissolved in 1.5 mL of
dry acetonitrile. The solution was combined with a solution of 190 mg (1 mmol)
c acid monohydrate in 1.5 mL of dry itrile. After addition of 0. 11 mL (1
mmol) p-iodoanisole, the mixture was allowed to react at room temperature for 2
hours. 10 mL of water was added to the reaction mixture followed by extraction with
3 X 5 mL hexanes. The water layer was treated with 502 mg (3 mmol) NaPF6. The
white precipitation was taken up in dichloromethane and recrystallization with
diethylether/dichloromethane provided 391 mg bis(p-methoxyphenyl)iodonium
hexafluorophosphate (80.5%).
90433785.
Example 5 - Preparation ofPhenyl—4-methoxypltenyliodoniam hexaflaorophosphate
Phenylmethoxyphenyliodonium hexafluorophosphate was synthesized
ing to the procedure described for the synthesis of bis(p—
methoxyphenyl)iodonium orophosphate from the corresponding aryliodonium
diacetate and e. (77.9%)
Example 6 - Preparation of2-methoxyplzenyl—4 ’-metlzoxyphenyliodoniam
hexaflaorophosphate
2-methoxypheny1-4’-methoxyphenyliodonium hexafluorophosphate was
1O synthesized ing to the procedure described for the synthesis of bis(p—
methoxyphenyl)iodonium hexafluorophosphate from the corresponding aryliodonium
diacetate and anisole. )
Example 7 - Preparation of3-cyanoplzenyl—4 ’—methoxyphenyliodoniam
kexafluorophosphate
3-cyanopheny1-4’-methoxyphenyliodonium hexafluorophosphate was
synthesized according to the procedure described for the synthesis of bis(pmethoxyphenyl
)iodonium hexafluorophosphate from the corresponding aryliodonium
ate and anisole. (73.7%)
Example 8 — Preparation of3-(trz’fluoromethy0phenyl—4 ’-methoxyphenyliodonium
hexaflaorophosphate
3 -(trifluoromethyl)pheny1—4’ —methoxyphenyliodonium hexafluorophosphate
was synthesized according to the ure described for the synthesis of bis(p—
methoxyphenyl)iodonium hexafluorophosphate from the corresponding aryliodonium
diacetate and anisole. (96.1%)
Example 9 - Preparation of2, 6-dimethoxyphenyl—4 ’-methoxyphenyliodoniam
hexaflaorophosphate
2,6-dimethoxyphenyl-4’-methoxypheny1iodonium hexafluorophosphate was
synthesized according to the procedure described for the synthesis of bis(p—
methoxyphenyl)iodonium hexafluorophosphate from the corresponding aryliodonium
diacetate and anisole. (86%)
2012/044954
24742411435705.
e 10 - Preparation 0f2-Br0m0-4, 5—dimethoxylbenzeneethanamine
2-Bromo-4, 5-dimethoxylbenzeneethanamine: Bromine (1.1 mL, 22 mmol) in
acetic acid (10 mL) was slowly added into a vigorously stirred solution of 2—(3,4—
dimethoxyphenyl)ethylamine (3.4 mL, 20 mmol) in 50 mL acetic acid. 2-bromo—4, 5—
dimethoxylbenzeneethanamine precipitated out after 15 minutes. The mixture was
stirred for another two hours, filtered, and washed with dichloromethane 10 mL X 3
and petroleum ether 10 mL X 3. The resulting solid was taken up in water and the pH
was brought to 10 with aqueous KOH solution. Extraction with romethane
followed by evaporation of the solvent yielded 4.12 g (78%) 2-Bromo—4, 5—
1O dimethoxylbenzeneethanamine. The crude product was dried under dynamic vacuum
ght and used without further purification.
Example 11 - Preparation 0f2—Br0m0-4, 5—dz'meth0xyl—(2-phthalimidoethybbenzene
2—Bromo-4, 5-dimethoxyl-(2-phthalimidoethy1)benzene: 2-Bromo-4, 5-
oxylbenzeneethanamine (3.5 g 13.2 mmol) was dissolved and stirred in 50 mL
dry acetonitrile. 2.14 mL (1.1 equiv) phthaloyl dichloride and 7 mL(3 equiv) Hfinig’s
base were added. The mixture was stirred at room temperature overnight. Acetonitrile
was then removed, and the remaining product was taken up in dichloromethane and
washed with basic water (pH=11). The aqueous wash was ted with
romethane 3 X 15 mL. The organic fractions were combined and dried over
sodium sulfate. Solvent was removed to give the crude product, which was then
purified by column chromatography. Calculated yield: 1.8g (34%).
Example 12 - Preparation of3, 4-dimeth0xyphenyllribalyltin
3,4-dimethoxyphenyltributyltin: Under N2 protection, 1.085 g (5 mmol) 4—
eratrole and 289 mg (5 mol%) Pd(0)(PPh3)4 was dissolved in 15 mL of dry
toluene, the solution was transferred into a e tube equipped with a Teflon
Chemcap Seal, and 3.19 g (5 mmol) hexabutylditin was added. The tube was sealed,
heated to, and kept at 1200 C for 48 hours. The reaction mixture was allowed to cool
to room temperature, and diluted with 15 mL hexane. 15 mL of saturated aqueous KF
solution was added and the mixture was stirred for 30 minutes followed by filtration
h celite. The organic layer was separated; t was d to provide the
crude product as a yellow oil. The crude was purified by column chromatography
(hexane/dichloromethane 98/2, basic aluminum) to give 1.69 g (79.1%) pure 3,4—
dimethoxyphenyltributyltin.
WO 03734
24742004333705.
Example 13 - Preparation of3, 4-dimethoxy—Z-methylphenyltribalyltin
3,4-dimethoxymethylphenyltributyltin was synthesized in a r fashion
as described in the procedure for the synthesis of 3,4—dimethoxyphenyltributyltin from
the corresponding bromo precursor. (76.2%)
Example 14 - Preparation of3, 4-dimeth0xy—2—(2-phthalimid0)phenyltribatyltin
3,4-dimethoxy(2-phthalimido)phenyltributyltin was synthesized in a similar
n as described in the ure for the synthesis of 3,4—
dimethoxyphenyltributyltin from the corresponding bromo precursor. (20%)
Example 15 - 3,4-a’imeth0xyphenyl—4 ’-mezh0xyphenyli0d0niam orophosplzate
3 ,4-dimethoxyphenyl-4’ -methoxyphenyliodonium hexafluorophosphate:
Under N2 protection, 352 mg (1 mmol) p—methoxyphenyliodonium ate was
dissolved in 1.5 mL of dry acetonitrile. The on was combined with a solution of
190 mg (1 mmol) tosylic acid monohydrate in 1.5 mL of dry acetonitrile. After
addition of 427 mg(l mmol) 3,4-dimethoxyphenyltributyltin, the mixture was
allowed to react at room temperature for 2 hours. 10 mL of water was added to the
reaction mixture followed by extraction with 3 X 5 mL hexanes. The water layer was
treated with 502 mg (3 mmol) NaPF6. The white precipitation was taken up in
romethane and recrystallization with diethylether/dichloromethane provided
370 mg (71.7%) 3,4—dimethoxyphenyl—4’—methoxyphenyliodonium
hexafluorophosphate.
Example I 6 - Preparation of 3, 4-dimeth0xy—2-melkylphenyl—4 ’-
methoxyphenyliodoniam hexafluorophosphale
3,4-dimethoxymethylphenyl—4’—methoxyphenyliodonium
hexafluorophosphate was synthesized in a similar fashion as 3,4-dimethoxyphenyl-4’—
methoxyphenyliodonium hexafluorophosphate from p-methoxyphenyliodonium
diacetate and the corresponding aryl tin precursor. (75%)
24742AGD43W81
Example I 7 - Preparation of 3, 4-dimethoxy—2—(2-phthalimidoethprhenyl-4 ’-
methoxyphenyliodoniam hexaflaorophosphate
3,4-dimethoxy(2-phthalimidoethyl)phenyl-4’-methoxyphenyliodonium
hexafluorophosphate hexafluorophosphate was synthesized in a r fashion as 3,4—
dimethoxyphenyl-4’-methoxyphenyliodonium hexafluorophosphate from p-
methoxyphenyliodonium diacetate and the corresponding aryl tin precursor. (55%)
Example 18 - Preparation of2-methoxypnenyl—4 ’-metlzoxyphenyliodoniamfluoride
2-methoxyphenyl-4’-methoxyphenyliodonium fluoride: Under N2 protection,
1O 97.2 mg (0.2 mmol) 2-methoxyphenyl-4’—methoxyphenyliodonium
hexafluorophosphate and 17.7 mg (0.95 equiv) anhydrous tetramethylammonium
fluoride (TMAF) were dissolved in 1 mL dry acetonitrile. The solvent was removed in
vacuo followed by addition of 5 mL of dry benzene. The insoluble TMAPF6 was
removed by filtration; the t was again removed in vacao to give 30.3 mg (42%)
oxyphenyl—4’ -methoxyphenyliodonium fluoride.
Example 19 - Preparation ofPlzenyl—4-methoxyphenyliodoniamfluoride
Phenylmethoxyphenyliodonium fluoride was synthesized in a r
n as the procedure described for 2-methoxyphenyl-4’-methoxyphenyliodonium
e from corresponding hexafluorophosphate. (96%)
Example 20 - Preparation of3-cyanophenyl—4 ’-methoxyphenyliodoniumfluoride
3-cyanophenyl—4’—methoxyphenyliodonium fluoride was synthesized in a
similar fashion as the procedure described for 2-methoxyphenyl-4’-
methoxyphenyliodonium fluoride from corresponding hexafluorophosphate. (25%)
Example 21 - ation rzfluoromethy0phenyl-4 ’-methoxyphenyliodonium
fluoride
3-(trifluoromethyl)phenyl-4’-methoxyphenyliodonium fluoride was
synthesized in a similar fashion as the procedure described for 2-methoxyphenyl-4’-
methoxyphenyliodonium fluoride from ponding hexafluorophosphate. (56%)
24742004333781
Example 22 - Preparation of2, 6-dimethoxyphenyl—4 ’-methoxyphenyliodoniam
fluoride
2,6-dimethoxyphenyl-4’-methoxyphenyliodonium fluoride was synthesized in
a similar fashion as the procedure described for oxyphenyl-4’-
methoxyphenyliodonium fluoride from corresponding hexafluorophosphate. (15%)
Example 23 - Preparation of3, 4-dimetlzoxyphenyl—4 ’-methoxyphenyliodoniam
fluoride
3,4-dimethoxyphenyl-4’-methoxyphenyliodonium fluoride was synthesized in
a similar fashion as the procedure described for 2—methoxyphenyl-4’-
methoxyphenyliodonium fluoride from corresponding hexafluorophosphate. (90%)
Example 24 - ation of3, 4—dimetlzoxy—2—methylphenyl—4 ’-
methoxyphenyliodoniamfluoride
3,4—dimethoxy-Z-methylphenyl-4’—methoxyphenyliodonium fluoride was
synthesized in a r fashion as the procedure described for 2-methoxyphenyl-4’-
methoxyphenyliodonium fluoride from corresponding hexafluorophosphate. (80%)
Example 25 - Preparation of3, 4-dimethoxy-Z-(Z—phthalimidoethprlzenyl-4 ’-
methoxyphenyliodoniamfluoride
3,4-dimethoxy—Z—(Z—phthalimidoethyl)phenyl-4’-methoxyphenyliodonium
fluoride was synthesized in a similar fashion as the procedure described for 2—
methoxyphenyl—4’—methoxyphenyliodonium fluoride from corresponding
hexafluorophosphate. (45%)
Example 26 - Preparation ofBis(p-methoxyphenyl)ioa’oniamfluoride
Bis(p-methoxyphenyl)iodonium fluoride: To a mixture of 454 mg (1 mmol)
methoxyphenyl)iodonium trifluoroacetate and 262 mg ) anhydrous
TBAF was added 1 mL of dry tetrahydrofuran (THF). The on was allowed to
stand for lhour, the white precipitate was collected and washed with 3 X 0.5 mL THF.
Calculated yield: 288.7mg (80.2%)
24742-04Il43WOi
Example 27 - Diaryliodoniumfluoride decomposition
In a glove box, 0.5 mL dry d6—benzene was added to 0.02 mmol of the
diaryliodonium fluoride, the solution/mixture was transferred to a J-Young NMR
tube. The tube was heated to and kept at 1400 C for 5 -15 minutes. The resulting
solution was analyzed by NMR and GC for product determination.
Observed yields of thermal ositions of the iodonium fluorides
prepared above are described in Table l.
24'}424’}043W01
Table 1.
I Yield of total
Entry Diaryliodonium fluoride fluoro Yield of ArF Conditions
aromatics
benzene
MGM)0 0 5744804)0 0 ’
140°C,15min
acetonitrile
650074)0 0 4047040 0
1400015000
0 0 e,
99 A0 (94)AD 86 4”" (80)4’)0 0
140°C, 18min
acetonitrile
43 A0(38)A00 0 43 “3 8 4’)0 0
140°C, 18min
benzene
82 A)(80 4’)0 0 49 “48 4’)0 0 ’
140°C, 15min
acetonitrile
60 A0(58 A0)0 0 40 A0(38A0)0 0
140°C, 15min
4? A0(44A0)0 0 19A0(17A0)0 0 9
140°C, 15min
benzene
89A0(90A0)0 0 89A0(90A0)0 0 ’
140°C 5 in
itrile
78A0 (77A0)0 0 78A0(77 A0)0 0
140°C 5min
I benzene
95 A0( 92 A0)0 0 85 A0(84)A0)0 0 ’
140°C, 10min
acetonitrile
67A0 (76A0)0 0 68 A0(76A0)0 0
140°C, 10min
(n0 benzene,
fluoroanisole 140°C, 15min
detected)
24742004333705.
benzene,
140°C, 15min
( ) determined by GC
* benzyne chemistry led to the formation of 3—fluoroanisole
Examples 28 - Impact ofadditional salts on F—MTEB.
The effect of salt present in solution during the decomposition of (3—cyano—5—
((2—methylthiazolyl)ethynyl)phenyl)(4—methoxyphenyl)iodonium triflate (Ar-
MTEB—OTf) was examined at 900 C in benzene and acetonitrile. Each solvent was
tested in the absence of salt, presence of 1 equivalent of salt, and presence of 2
equivalents of salt. The preparation of each reaction ion is summarized below.
A TMAF stock solution of 3.3 mg/mL in dry, ed acetonitrile was prepared for
on to each reaction tube.
B-OTf
Acetonitrile no salt
Iodonium triflate precursor (0.004 g, 6.6 umol) was ved in 0.38 mL of
dry, degassed acetonitrile, under nitrogen atmosphere, with 18 uL of TMAF (6.6
umol) stock solution. Next, 0.4 mL of dry, degassed benzene was added to the residue
and passed twice through 0.22 um PTFE membrane filter. The solution was again
subjected to vacuum to remove solvent and the remaining residue was dissolved in 0.4
mL of dry, degassed tonitrile. The reaction mixture was placed in a silicon oil
bath and monitored at 90 °C.
24742004333705.
Acetonitrile + 1 eg. TMAOTf
Under nitrogen atmosphere, iodonium triflate precursor (0.004 g, 6.6 umol)
was dissolved in 0.38 mL dry, degassed d3—acetonitrile, and combined with 18 uL of
TMAF (6.6 umol) stock solution. The reaction e was placed in silicon oil bath
and monitored at 90° C.
Acetonitrile + 2 eg. TMAOTf
Under nitrogen atmosphere, iodonium triflate precursor (0.004g, 6.6 umol)
was dissolved in 0.38 mL dry, degassed d3—acetonitrile and combined with 18 ”L of
TMAF (6.6 umol) stock solution, with a subsequent addition of
tetramethylammonium triflate (0.0015g, 6.6 umol) to the reaction mixture. The
solution was then placed in a n oil bath and monitored at 90° C.
Benzene no salt
Under nitrogen atmosphere, iodonium triflate precursor g, 6.6 umol)
was dissolved in 0.38 mL dry degassed acetonitrile and ed with 18 uL of
TMAF (6.6 umol) stock solution. The itrile was removed by vacuum and the
remaining residue was redissolved in 0.4 mL dry, ed d6-benzene. The solution
was passed twice through 0.22 pm PTFE filter, sealed under nitrogen, and monitored
in silicon oil bath at 90° C.
Benzene + 1 eg. TMAOTf
Under nitrogen atmosphere, um triflate precursor (0.004g, 6.6 umol)
was dissolved in 0.38 mL dry, degassed acetonitrile and combined with 18 ”L of
TMAF (6.6 umol) stock solution. The acetonitrile was removed by vacuum and the
remaining residue was redissolved in 0.4 mL dry, ed d6—benzene. The on
mixture was sealed under nitrogen and monitored in silicon oil bath at 90 °C.
Benzene + 2 eg. TMAOTf
Under nitrogen atmosphere, iodonium triflate precursor (.004g, 6.6 umol) was
dissolved in 0.38 mL dry, degassed d3—acetonitrile and combined with 18 uL of
TMAF (6.6 umol) stock solution, with a subsequent addition of
tetramethylammonium triflate g, 6.6 umol) to the reaction mixture. The
24742004333705.
acetonitrile was removed by vacuum and the remaining residue was redissolved in 0.4
mL d6-benzene. The solution was then placed in a silicon oil bath and monitored at 90
The results of these experiments are shown in FIGs. l and 2. It is clear that
added salt has a large negative impact on the yield of the reaction in itrile, but
not as significant an impact on the results for the decomposition reaction performed in
the nonpolar t benzene. This latter result may be due to the fact that TMAOTf
is only sparingly soluble in benzene.
Example 29 — Fluorinations ofradiofluorination ofMTEB under conventional
conditions
For each reaction the um precursor Ar—MTEB-OTf (2 mg) was
vent in 300 uL of either acetonitrile, DMF, or DMSO.
Preparation of Kryptoflx 222/K2CO3 18F source: A mixture of 50—100 11L of
H20 with [18F]fluoride + 15 uL of 1 M ch03 (aq) + 800 uL CH3CN was heated
for 3 s in a microwave cell at 20 W. The mixture was treated with 800 uL of
CH3CN and heated again. Excess solvent was removed under a stream of dry nitrogen
at 80° C.
Run 1: A solution of Ar—MTEB—OTf (2 mg) in 300 uL DMF was added to the
dried Kryptofix 222/K2CO3 KlgF source and heated in a microwave (50 W, 1.5 min).
No able radiolabeled MTEB was seen by radio-TLC. Additional ave
heating for 3 or 6 minutes resulted in no EB.
Run 2: A solution of Ar-MTEB—OTf (2 mg) in 300 uL DMSO was added to
the dried Kryptoflx 222/K2CO3 KISF source and heated in a conventional oil bath at
120° C for 15 minutes. No detectable radiolabeled MTEB was seen by radio—TLC.
Further heating for 15 or 30 minutes resulted in the formation of no detectable 18F-
MTEB.
For runs 3 and 4, a solution of [18F]TBAF was prepared by addition of
TBAOH to the [180]H20 on containing [18F]fluoride. Drying was performed in
24742004333705.
vacuo. The resulting solid was treated with 800 uL of CH3CN and dried by heating to
80° C under a stream of dry nitrogen.
Run 3: A solution of Ar-MTEB-OTf (2 mg) in 300 uL DMF was added to the
[18F]TBAF and heated in at 150° C oil bath for 15 minutes, 30 minutes, and one hour.
No detectable radiolabeled MTEB was seen by radio—TLC.
Run 6: A solution of Ar—MTEB-OTf (2 mg) in 300 uL DMSO was added to
the [18F]TBAF and heated in at 120° C oil bath for 15 minutes, 30 minutes, and one
hour. A yield of 6.3% of radiolabeled MTEB was seen by radio—TLC.
Example 30 - Preparation ofI8F—MTEB with salt removal.
[18F]TBAF was dried twice with MeCN at 90° C under reduced pressure (-10
mmHg). Ar—MTEB—OTf (2 mg) was ved in MeCN (300 uL) and added to the
vial containing the dried [18F]TBAF. The reaction mixture was stirred at 90° C and
the MeCN was evaporated under d pressure (- 10 mm Hg). The remaining
residue was re-dissolved in 2 mL of dry benzene, passed through 0.22-mm syringe
filter, and heated to 100° C for 20 minutes (radiochemical yield (RCY)= ca 70 %,
determined by radio-HPLC and radio-TLC)
Example 31 - Preparation MTEB with salt removal.
BAF was dried twice with MeCN at 90° C under reduced pressure (—10
mmHg). Ar—MTEB—OTf (2 mg) was ved in MeCN (300 uL) and added to the
vial containing the dried [18F]TBAF. The reaction e was stirred at 90° C and
the MeCN was evaporated under reduced pressure (-10 mm Hg). The remaining
residue was re—dissolved in 2 mL of dry benzene, passed through 0.22—mm syringe
filter, and heated to 130° C for 20 minutes (radiochemical yield (RCY)= ca 90 %,
determined by radio-HPLC and radio-TLC)
24’}42J)043WGE
Example 32 - Preparation ]-6—FIaoro—L-DOPA.
O O
t'BuxoiNJJxO/t-Bu
MeO\©\ 5
I O
Ar—LDOPA-OTf
Ar—LDOPA—OTf (2 mg) is dissolved in 300 uL of dry acetonitrile and added to
a vial containing dry [18F]TBAF. The solution is warmed to 90° C and the solvent is
removed under reduced pressure. Dry toluene (500 uL) is added to the residue and the
solution is passed through a 0.22 pm PTFE ne filter and heated (in a sealed
vessel) to 130° C for 20 minutes. The solvent is removed under reduced pressure and
the residue is treated with 48% HBr (500 uL) and heated at 140° C for 8 minutes to
remove the protecting groups. The [18F]F1uoro-L-DOPA is purified by reverse
phase chromatography.
Example 33 - Generalprocedurefor the preparation offluorinated aryl amino acids
and their derivatives.
The appropriate (4—methoxypheny1)ary1iodoniumtriflate (2—3 mg) is dissolved
in 300 uL of dry itrile and added to a vial containing dry [18F]TBAF. The
solution is warmed to 90° C and the solvent is removed under reduced pressure. Dry
toluene or benzene (500 uL) is added to the e and the solution is passed through
a 0.22 pm PTFE membrane filter and heated (in a sealed ) to 130° C for 20
minutes. The solvent is removed under d pressure and the residue is treated
with 48% HBr (500 uL) and heated at 140° C for 8 minutes to remove the protecting
groups. The [18F]—fluorinated aryl amino acid or tive is purified by reverse
phase chromatography.
Example 34 - Preparation 0f6—FZa0r0-L-DOPA.
The precursor Ar—LDOPA—OTf (20 mg) was dissolved in 0.7 mL of dry
CD3CN and treated with one equivalent . The solvent was removed and the
2012/044954
24742004333705.
residue was dissolved in 0.7 mL of d6—benzene, placed in an NMR tube equipped with
a PTFE valve, and heated to 140 0C for 20 minutes. 1H and 19F NMR spectra (FIGs. 3
and 4) indicated that the yield of the reaction was 85% and that the yield of 4-
fluoroanisole was approximately 1%.
Example 35 - Deprotection 0f6—FIu0r0-L—DOPA.
The solvent was removed from the reaction mixture containing crude 6-fluoro—
L—DOPA (Example 34). The residue was dissolved in 1 mL of 48% aqueous HBr and
the solution was heated to 140 °C for 10 minutes. The solution was neutralized with
sodium onate and the water was evaporated. 1H and 19F NMR spectra (D20)
were identical to the authentic standard, as was confirmed by adding independently
obtained 6-fluoro-L-DOPA to the NMR tube.
Example 36 — Contaminant salts removed by size exclusion chromatography
To demonstrate the efficacy of this size exclusion chromatography, the
following procedure was utilized. A Jordi Gel DVB 100 A column (250 mm) was
equilibrated with acetonitrile for 30 minutes prior to injection. Acetonitrile solutions
of tris(neopenty1)methylammonium tosylate and bis(4-methoxyphenyl)iodonium
fluoride were ed (1 mg/mL) and the two ons were mixed together and
stirred for 5 minutes. A 10 uL aliquot of the mixed solution was injected for analysis
into the Jordi Gel . The mixture was separated via size—exclusion
chromatography under a pressure of 1500 psi, flow rate of 0.7 mL/min, and followed
by UV detection.
ing elution, bis(4-methoxypheny1)iodonium fluoride showed a retention
time of 10.26 minutes eopentyl)methy1ammonium tosylate showed a retention
time of 11.87 minutes. The identity of the eluted materials was confirmed by
ng the retention times to those of purified standards.
The HPLC chromatogram demonstrates that the tetraalkylammonium tosylates
can be removed cleanly from diaryliodonium fluorides using this technique. It should
be emphasized that this is a particularly challenging example of a separation, since
this chromatographic technique works by entiating the solutes in terms of their
l size. Here the iodonium salt is only slightly larger than the
tetraalkylammonium te contaminant. In order to synthesize radiotracers from
24742AK’M4SWOE
iodonium salts, the precursors of interest will be significantly larger than in the
example given here, and the competing anions will generally be r than tosylate.
A number of embodiments of the invention have been described.
Nevertheless, it will be understood that various modifications may be made without
departing from the spirit and scope of the invention. Accordingly, other embodiments
are within the scope of the following claims.
Claims (30)
1. A method for making a compound of Formula (3): ArZ—F wherein: Ar2 is a substituted or unsubstituted aryl or heteroaryl ring system; and F is a radioactive isotope of fluorine; the method comprising: a) first reacting in a polar solvent a compound MF, wherein M is a counter ion and F is a radioactive isotope of fluorine, and a compound of a (2): A 1——Ir wherein: ArI is a tuted or unsubstituted electron rich aryl or heteroaryl ring system; Y is a leaving group; and Ar2 is as defined above; b) ng contaminant salts from the solution comprising the reaction product ofMF and the compound of Formula (2) of step a) by chromatography; and c) heating the eluted on of step b) comprising the reaction product of MF and the compound of Formula (2) of step a) to prepare the compound of Formula (3).
2. A method for making a compound of a (3): Arz—F wherein: Ar2 is a substituted or unsubstituted aryl or heteroaryl ring system; and F is a radioactive isotope of fluorine; the method comprising: a) first ng in a ar solvent a compound MF, n M is a counter ion and F is a radioactive isotope of fluorine, and a compound of Formula (2): Ar1-|/ wherein: Arl is a substituted or unsubstituted electron rich aryl or heteroaryl ring system; Y is a leaving group; and Ar2 is as defined above; b) removing contaminant salts from the solution comprising the reaction product ofMP and the compound ofFormula (2) of step a) by chromatography; and c) g the eluted solution of step b) comprising the reaction product of MF and the compound of Formula (2) of step a) to prepare the compound of Formula (3).
. The method of any one of claims 1 and 2, wherein Arl is substituted with at least one substituent having'a Hammett 61, value of less than zero.
. The method of claim 3, wherein the substituent is selected from the group ting of ~(C1- C10)alkyl, ~(C1—C10)haloalkyl, (Cg—Clo)alkenyl, (Cg-Clo)alkynyl, —O—(C1—C10)alkyl, —C(O)—O— (C1—C10)alkyl, aryl, and aryl.
. The method of any one of claims 1-4, wherein Ar1 and Ar2 are the same.
. The method of any one of claims 1 and 2, wherein Arl is: wherein: R1, R2, R3, R4, and R5 are independently selected from the group consisting of : H, -(C1— C10)alkyl, -(C1-Cio)haloalkyl, (C2—C10)alkenyl, (C2—C1o)alkynyl, -O—(C1—C10)alkyl, -C(O)— O—(C1-C10)alkyl, aryl, and heteroaryl, or two or more of R1, R2, R3, R4, and R5 come together, with the carbon atoms to which they are bound, to form a fused aryl or heteroaryl ring system.
7. The method any one of claims 1—4, wherein Ar2 is selected from the group consisting of: a phenylalanine, tyrosine, phan, histidine, and an estradiol.
8. The method of any one of claims 1—4, wherein Ar2 is selected from the group consisting of: OMe CN MeO OMe OMe CFa N, N \P5 \P5 25‘ o \x 0 0 0P3 /E OP4 0P4 0P4 , , 2 P1 2 P1\N’P2 N P5 O\P5 O\ o 0 F) a: 0 0P3 0P3 0P3 , . ’ Pl ,P2 Pl P2 1 \ (P N N/ 0 0\ \P5 P5 \g 0 0 0 , ’ I a lN’P2 1 P2 1 \ /P2 N \N/ O o\ \P5 P5 0 O / N / ‘9? N_.// N [5* 0P3 Pg 6/ P 0P4 1 \ P2 \ N/ P2 N/ 0/12) l P2 1,P2 p1 p2 1 P2 N \N’ \N, p3 3 3 \o \ P\ \ R \ O O \ N N P6 ‘P5 \P6 P\N/1 l J32 l /P2 1 P2 N N \N/ P ‘O7 P o7. P 07. p70 0P3 0P3 0P3 0P3 9 3 9 1 2 1 2 P\N/P \N’P P7 0 P70 0 0P3 OF’3
9 0P4 7 CN 9 / / I l \ \ f-‘QN‘ \ N Q N Q \ CN CN , , <\ \ RN N \ \ § 5 P40 and CN CN P4-o wherein: each of P1 and P2, and P6 are independently a en ting group, or P1 and P2 come together, with the N atom to which they are bound, to form a single nitrogen protecting group; each of P3, P4 and P7 are independently an alcohol protecting group, or P3 and P4 come together, with the atoms through which they are bound, to form a single oxygen protecting group; and P5 is a carboxylic acid protecting group. The method of any one of claims 2—8, wherein the ar solvent is selected from the group consisting of: benzene, toluene, ne, m—xylene, p-Xylene, ethyl benzene, carbon tetrachloride, hexane, cyclohexane, fluorobenzene, chlorobenzene, nitrobenzene, and mixtures thereof.
10. The method of claim 9, wherein the nonpolar solvent comprises toluene.
ll. The method of any one of claims 1—10, wherein the heating comprises heating at a temperature ranging from about 25° C to about 250° C.
12. The method of any one of claims 1—1 1, wherein the heating occurs for from about 1 second to about 25 minutes.
13. The method of any one of claims 1—12, wherein the heating is accomplished by a flash pyrolysis method, a conventional heating method, or by a ave method.
14. The method of any one of claims 1, 2—8, and 11—13, wherein the polar solvent is selected from the group consisting of: acetonitrile, acetone, dichloromethane, ethyl acetate, tetrahydrofuran, ylformamide, fluorobenzene, benzotrifluoride and mixtures thereof.
15. The method of any one of claims 1-14, wherein Y is selected from the group consisting of triflate, mesylate, nonaflate, hexaflate, tosylate, nosylate, brosylate, perfluoroalkyl sulfonate, tetraphenylborate, hexafluorophosphate, trifluoroacetate, tetrafluoroborate, perchlorate, perfluoroalkylcarboxylate, de, bromide, and iodide.
16. The method of any one of claims 1—15, wherein M is selected from the group consisting of: potassium, sodium, cesium, xes of lithium, sodium, potassium, or cesium with cryptands or crown ethers, tetrasubstituted ammonium cations, and phosphonium cations.
17. The method of any one of claims 1, 2, and 9—16 wherein the compound of a (2) is selected from the group consisting of: PlN/PZ PlN,P2 PlN’Pz 0\ 0\ Y P5 Y P5 0\ Arl/l O Arl/l O 0 OP3 AFH 0P4 0P4 , t 0P4 , PLNJD2 P1 2 1 \N/ P2 P\N,P O\ O\ Y P5 P5 P5/O 1 Y /| O O O Ar1 |\Arl 0P3 0P3 and , , 0P3 Y \Ar1 wherein: each of Pland P2 are independently a nitrogen protecting group, or P1 and P2 come together, with the N atom to which they are bound, to form a single nitrogen protecting group; each of P3, and P4 are independently an alcohol protecting group, or P3 and P4 come together, with the atoms through which they are bound, to form a single oxygen protecting group; P5 is a carboxylic acid protecting group.
18. The method of any one of claims 1, 2, and 9-16, wherein the compound of Formula (3) is selected from the group consisting of: PlN,P2 PlNPZ PlN,P2 O\P5 O\P5 O\P5 F o F o 0 OP3 F 0P4 OP4 0P4 , 3 2 1 PlN/PZ P1\N,P2 P\N’P O F F o 0 0P3 0P3 , and wherein: each of P1 and P2 are independently a nitrogen protecting group, or P1 and P2 come er, with the N atom to which they are bound, to form a single en protecting group; each of P3, and P4 are independently an alcohol protecting group, or P3 and P4 come together, with the atoms through which they are bound, to form a single oxygen protecting group; P5 is a ylic acid protecting group; and F is a radioactive isotope of fluorine.
19. The method of any one of claims 1, 2, and 9—16, wherein the compound of Formula (2) is selected from the group consisting of: / / O I \ Y Y Y N \ l \Nl \ I % l\ \ \ 0 1 |\Ar1 [\Ar1 CN CN CN 5 3 S 4\ \ l ./N Y <\ Y / Y N N % i \\ i Q i \Ar1 \Ar‘ \Ar1 CN , CN ,and ON
20. The method of any one of claims 1, 2, and 9—16, wherein the compound of Formula (3) is ed from the group consisting of: / / O I I N \ \N \ Q \ F \ F CN CN CN , , , S S RN ,,<\ \ (\N \ ’IN N § F \\ F \\ F ’ and CN CN = ON and F is a radioactive isotope of fluorine.
21. The method of any one of claims 1, 2, and 9—16, wherein the compound of Formula (2) is selected from the group consisting of: wherein: each of P3 and P4 are independently an alcohol ting group.
22. The method of any one of claims 1, 2, and 9—16, wherein the compound of Formula (3) is selected from the group consisting of: 0P3 . 4 mg; F and P '0 wherein: each ofP3 and P4 are independently an alcohol protecting group.
23. The method of any one of claims 1, 2, and 9—16, wherein the compound of Formula (2) is: P \N/P1 2 Y “PS Arl/I O wherein: each of P1 and P2 are independently a nitrogen protecting group, or P1 and P2 come together, with the N atom to which they are bound, to f01m a single nitrogen protecting group; each of P3, and P4 are independently an l protecting group, or P3 and P4 come together, with the atoms through which they are bound, to form a single oxygen ting group; P5 is a carboxylic acid protecting group.
24. The method of any one of claims 1, 2, and 9—16, wherein the compound of Formula (2) is: O O t—Bu\OJLNAO/t—Bu Y ““Sflk Arl/i O
25. The method of any one of claims 1, 2, and 9—16, wherein the compound of Formula (2) is: O O t-Bu \O/IL NAO/t-Bu M800 _: /' 0
26. The method of any one of claims 1, 2, and 9—16, wherein the compound of Formula (3) is: wherein: each of P1 and P2 are ndently a nitrogen protecting group, or P1 and P2 come together, with the N atom to which they are bound, to form a single nitrogen protecting group; each of P3, and P4 are independently an alcohol protecting group, or P3 and P4 come together, with the atoms through which they are bound, to form a single oxygen ting group; P5 is a carboxylic acid protecting group; and F is a radioactive isotope of fluorine.
27. The method of any one of claims 1, 2, and 9—16, wherein the compound of Formula (3) is: O O t-Bu\ /U\ JL /t-Bu and F is a radioactive isotope of e.
28. The method of any one of claims 1, 2, and 9—16, wherein the compound of Formula (3) is: F 0 and F is a radioactive isotope of fluorine.
29. The method of any one of claims 1-28, wherein the chromatography is size ion chromatography.
30. The method according to any one of claims 1 to 29 and substantially as herein described with reference to the Examples and/or Drawings.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/172,953 US9302990B2 (en) | 2008-10-21 | 2011-06-30 | Fluorination of aromatic ring systems |
US13/172,953 | 2011-06-30 | ||
PCT/US2012/044954 WO2013003734A2 (en) | 2011-06-30 | 2012-06-29 | Fluorination of aromatic ring systems |
Publications (2)
Publication Number | Publication Date |
---|---|
NZ619465A NZ619465A (en) | 2016-01-29 |
NZ619465B2 true NZ619465B2 (en) | 2016-05-03 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2537826B1 (en) | Fluorination of aromatic ring systems | |
CA2840608C (en) | Fluorination of aromatic ring systems | |
JP6405573B2 (en) | Method for producing 4-borono-L-phenylalanine having 18F atoms introduced and precursor of 4-borono-L-phenylalanine having 18F atoms introduced | |
JP6563401B2 (en) | Radioiodinated compounds | |
US8546578B2 (en) | Iodonium Cyclophanes for SECURE arene functionalization | |
AU2013334166A1 (en) | Processes and reagents for making diaryliodonium salts | |
JP2015523985A (en) | Methods and reagents for producing diaryliodonium salts | |
NZ619465B2 (en) | Fluorination of aromatic ring systems | |
AU2013203523B2 (en) | Fluorination of aromatic ring systems | |
AU2015264872A1 (en) | Fluorination of aromatic ring systems | |
EP2511261A1 (en) | Composition, synthesis and use of isonitriles |